close

Jorge Flores

Recently Diagnosed with Pancreatic Cancer | Sky Foundation Guide – TEST

Next Steps After a Pancreatic Cancer Diagnosis

Being diagnosed with pancreatic cancer can feel overwhelming. This page provides accurate information, structured guidance, and trusted resources to help you understand your diagnosis and take your next steps with confidence.

Table of Contents

1) Start Here
Understanding Your Diagnosis
What it is, types, and staging basics.

 

 

2) Do This Next
Next Steps After Diagnosis
Your step-by-step checklist.

 

 

3) Options
Treatment Options
Surgery, chemo, radiation, more.

 

 

4) Consider Early
Clinical Trials Access
Match your case to trials.

 

 

5) Get Help
Resources for Patients & Caregivers
Financial, caregiver, navigation.

 

 

6) Quick Definitions
Glossary & FAQ
Common terms & questions.

 

Understanding Your Diagnosis

Pancreatic cancer begins in the pancreas, an organ that helps regulate blood sugar and produces enzymes for digestion.
The most common type is pancreatic ductal adenocarcinoma (PDAC), which arises in the ducts of the pancreas.
Less common types include neuroendocrine tumors.

Staging (localized, borderline resectable, locally advanced, or metastatic) is determined through imaging (CT, MRI, EUS) and biopsy.

Next Steps After Diagnosis

Use this checklist to stay organized and move forward with clarity. You don’t have to do everything at once—start with Step 1 and build from there.

Step 1
Confirm Your Diagnosis and Stage
Use imaging, biopsy, and bloodwork (including CA 19-9) to confirm the diagnosis and determine the stage of pancreatic cancer.
Step 2
Seek a Second Opinion
Outcomes often improve when care is coordinated through high-volume cancer centers. Sky Foundation partners closely with
Henry Ford Health,
Karmanos Cancer Institute, and the
University of Michigan Rogel Cancer Center—and we can help connect you directly to any of these hospital systems upon request.

Step 3
Understand Your Treatment Pathways
Common options include surgery, chemotherapy, radiation, clinical trials, and palliative care. Understanding each pathway helps you and your care team make informed decisions tailored to your needs.
Step 4
Explore Clinical Trials Early
Access to new and emerging therapies can improve survival and quality of life. We recommend
TriCan Health,
which can match your specific case details to active clinical trials that may be the best fit for you.
Step 5
Build a Multidisciplinary Care Team
Assemble a team that includes experienced surgeons, oncologists, gastroenterologists, and nutritionists. If you’re a candidate for the
Whipple procedure, research your surgeon carefully—experience matters. Look for someone who has performed hundreds, ideally thousands of successful Whipple surgeries.
Step 6
Prepare for Appointments
Bring a trusted caregiver and a written list of questions to each visit. Staying organized ensures you get the answers and support you need.
Refer to our
questions for yourself and your medical team page.

Treatment Options

🩺 Surgery
Whipple procedure, distal pancreatectomy, or total pancreatectomy (curative intent).
💉 Chemotherapy
FOLFIRINOX, gemcitabine + nab-paclitaxel, or gemcitabine alone.
☢️ Radiation Therapy
For borderline resectable or locally advanced disease, or symptom relief.
🧬 Targeted Therapy & Immunotherapy
PARP inhibitors for BRCA1/2 mutations; pembrolizumab for MSI-H tumors.
🧪 Clinical Trials
Options may be available at multiple stages of care—not just as a last resort.
🤝 Palliative Care
Pain management, nutrition counseling, enzyme replacement, and emotional support.

Clinical Trials Access

Clinical trials test new therapies, including targeted drugs and immunotherapies. Patients often benefit from enrolling early.
Clinical trials are often looked at when patients “have no other options.” But in the words of pancreatic cancer survivor, Kay Kays:
“Clinical Trials should be the appetizer, not the dessert.”

Resources for Patients & Caregivers

Support & Emotional Well-Being

🧠 Counseling & Mental Health
Emotional health is an important part of your care. Oncology social workers, psychologists, and cancer support groups can help manage anxiety, depression, and the emotional challenges that come with a diagnosis.
🫶 Peer Support Communities
At Sky Foundation, our community includes many individuals who have personally experienced a pancreatic cancer diagnosis. They offer understanding, encouragement, and guidance.
Join our Facebook Support Group or consider joining one of our
Boards or Committees.
🧍‍♀️ Caregiver Health
Caring for a loved one with pancreatic cancer can be emotionally and physically demanding. Caregiver-focused programs and respite care can help prevent burnout. We recommend reaching out to Gilda’s Club for trusted caregiver support and resources.
🌿 Integrative Therapies
Incorporating practices such as meditation, yoga, gentle exercise, and nutrition support can improve overall well-being and quality of life during treatment.
💜 Connect with a Sky Advocate
Many of our Board Members, Committee Members, and volunteers are either survivors or have supported a loved one through a pancreatic cancer path.
We would be happy to connect you with someone who understands what you’re going through.

Contact Annie to be matched with a supportive Sky Advocate:
📧 Annie@SkyFoundationInc.org
📞 248-385-5143

Glossary & FAQ

Adenocarcinoma: Most common pancreatic cancer type.
Biopsy: Tissue sampling to confirm diagnosis.
CA 19-9: Tumor marker used for monitoring, not diagnosis.
EUS (Endoscopic Ultrasound): Imaging test for detailed pancreas evaluation.
Whipple Procedure: Complex surgery for tumors in the head of the pancreas.
Palliative Care: Specialized care to improve quality of life alongside treatment.

FAQ Highlights

  • How is staging determined? – Imaging, biopsy, and tumor spread.
  • Should I get genetic testing? – This can be an important conversation with your medical team. (Your care team can advise based on your situation.)
  • What if surgery isn’t possible? – Options include chemotherapy, radiation, targeted therapy, or clinical trials.
  • Where can I find clinical trials?TriCanHealth.com (and ClinicalTrials.gov).

Closing Note

Pancreatic cancer care requires expert guidance, advanced treatments, and strong support systems. At Sky Foundation, we are here to connect patients and caregivers with top medical teams, clinical trial opportunities, and a supportive community that understands this journey.

read more

Caregiver & Family Resources

Caring for someone with pancreatic cancer is both a powerful act of love and an overwhelming responsibility. Whether you are a spouse, family member, or friend, your role is critical—not only in supporting your loved one, but in maintaining your own strength along the way.

This resource hub is designed for you. Inside, you’ll find practical tools, emotional guidance, and trusted information to help you navigate every stage of the caregiving journey. From managing treatment schedules to caring for your own well-being, these articles provide the knowledge and reassurance you need.

What You’ll Find Here

  • Understanding the Caregiver Role – What it means to be a caregiver, and how to balance advocacy with self-care.
  • Supporting Through Treatment – Tips on communication, managing symptoms, and helping with daily needs.
  • Emotional Well-Being – Resources for coping with stress, guilt, and burnout.
  • Financial & Practical Tools – Guidance on health insurance, clinical trials, and planning for in-home or hospice care.
  • Support for Families & Friends – Advice for spouses, parents, children, teens, and friends walking alongside a loved one.
  • Building a Support Network – How to connect with others who understand this journey.
  • End-of-Life & Grief Support – Tools for navigating difficult conversations and finding healing after loss.

You are not alone. Caregiving can feel isolating, but this community of resources is here to strengthen and support you every step of the way.

Table of Contents

  1. Understanding the Caregiver Role
    • What it means to be a caregiver
    • Balancing advocacy and personal well-being
    • Common challenges caregivers face
  2. Supporting Your Loved One Through Treatment
    • Communicating with the medical team
    • Managing appointments, medications, and symptoms
    • Helping with nutrition, mobility, and daily needs
  3. Coping With the Emotional Impact
    • Supporting your loved one’s mental health
    • Managing caregiver stress, guilt, and burnout
    • When to seek professional counseling
  4. Practical & Financial Considerations
    • Navigating health insurance and bills
    • Understanding clinical trial logistics
    • Planning for in-home care or hospice
  5. Resources for Spouses, Family & Friends
    • How spouses can balance marriage and caregiving
    • Supporting children and teens in the family
    • Ways friends can help meaningfully
  6. Building Your Support System
    • Finding caregiver support groups
    • Connecting with other families
    • Online and local resources for pancreatic cancer caregivers
  7. End-of-Life Care & Grief Resources
    • Understanding palliative vs. hospice care
    • Preparing for difficult conversations
    • Grief support for family and friends
  8. Post-Recovery Care & Preventing Recurrence
    • Supporting survivors after treatment
    • Emotional healing after recovery
    • Healthy lifestyle choices to reduce recurrence risk
  9. Caregiver FAQ & Glossary
    • Quick answers to common caregiver questions
    • Key caregiving and medical terms defined
read more

Understanding the Caregiver Role

Guidance for caregivers navigating responsibilities, challenges, and self-care.

Overview: Caregiving is more than logistics—it’s emotional, physical, and mental support.

  • Defining what it means to be a caregiver
  • Common responsibilities (advocacy, daily support, logistics)
  • Challenges: exhaustion, role changes, and isolation

Understanding the Caregiver Role

Caring for someone with pancreatic cancer is one of the most important—and often most difficult—roles you may ever take on. Caregivers are more than helpers; they are advocates, organizers, and companions on one of life’s hardest journeys. At Sky Foundation, we know this intimately—our board, committees, and communities are filled with survivors, caregivers, and families who have walked this path before. You are not alone.

What It Means to Be a Caregiver

A caregiver can be a spouse, partner, parent, child, sibling, or friend who provides physical, emotional, or logistical support. Every caregiving journey looks different, but common responsibilities include:

  • Medical support: Attending appointments, tracking symptoms, and helping with medications.
  • Advocacy: Asking questions and ensuring your loved one’s voice is heard.
  • Daily care: Assisting with meals, mobility, and household needs.
  • Emotional presence: Offering encouragement and comfort during hard moments.
  • Logistics: Coordinating schedules, insurance, and communication with family members.

 

Balancing Advocacy & Self-Care

Many caregivers focus so much on their loved one that they forget about themselves. But maintaining your own health is essential for long-term caregiving.

  • Prepare questions for doctors: Your advocacy ensures clear communication.
  • Set boundaries: It’s okay to ask others to share responsibilities.
  • Prioritize rest and nutrition: Small acts of self-care build resilience.
  • Accept help: Let friends cook a meal, run errands, or provide respite care.

Sky Foundation offers caregiver committees where you can connect with people who’ve managed the same balance—strong advocates who also learned the importance of self-care.

 

Common Challenges Caregivers Face

It’s normal to experience stress, fatigue, and changing family dynamics as a caregiver. Acknowledging these challenges is the first step to overcoming them.

  • Physical strain: Lifting, long hospital visits, and irregular sleep.
  • Emotional stress: Anxiety, sadness, or guilt when you can’t “do it all.”
  • Changing roles: A spouse becomes a full-time caregiver, or a child takes on adult responsibilities.
  • Isolation: Friends and extended family may not fully understand your experience.

Sky Foundation’s survivor- and caregiver-led communities provide a space where these challenges are understood and shared.

 

Coping Strategies for Caregivers

Practical steps can make the caregiving journey more sustainable:

  • Create structure: Use calendars and to-do lists to reduce mental load.
  • Build a support system: Identify friends, relatives, or professionals who can step in when needed.
  • Stay connected: Join caregiver support groups to reduce feelings of isolation.
  • Seek counseling when needed: Professional help can provide tools for stress, grief, and resilience.

Building Strength Through Community

No caregiver should have to walk this journey alone. At Sky Foundation, our community is filled with compassionate advocates who have walked a similar path. Many find healing and purpose by serving on our Boards, Committees, or through volunteer opportunities—supporting families who are now facing what they once experienced.

Our Sky Support Circle includes pancreatic cancer survivors and dedicated advocates who offer encouragement, understanding, and guidance along the way.

If you’d like to be connected with a Sky Advocate, reach out to Annie Dalton, Sky’s Executive Director. She will personally connect you with someone whose experience closely aligns with yours.

📧 Annie@SkyFoundationInc.org
📞 248-385-5143

Legacy of Care

Caregiving leaves an impact far beyond the immediate journey. Sky Foundation’s Legacy Giving program offers a way to honor your caregiving role by supporting research, survivor-led programs, and caregiver resources through your will or estate. You can even choose the specific projects or initiatives you want to support, ensuring your love and care continue to shape the future of pancreatic cancer support.

 

Key Takeaway

Being a caregiver for someone with pancreatic cancer is one of the hardest jobs, but also one of the most meaningful. By balancing advocacy with self-care, acknowledging challenges, and connecting with supportive communities, you can walk this path with strength. Sky Foundation stands with you, offering survivor-led leadership, caregiver committees, and Legacy Giving opportunities to ensure your caregiving journey creates a lasting impact.

read more

Supporting Your Loved One Through Treatment

Practical advice on appointments, medications, nutrition, and clinical trials.

Overview: Practical ways caregivers can help during diagnosis, treatment, and recovery.

  • Communicating with doctors and nurses
  • Tracking medications, appointments, and symptoms
  • Helping with nutrition, mobility, and daily routines
  • Encouraging participation in clinical trials if eligible

Supporting Your Loved One Through Treatment

Supporting a loved one through pancreatic cancer treatment is a demanding but deeply meaningful role. Treatments may include surgery, chemotherapy, radiation, immunotherapy, or participation in clinical trials. As a caregiver, you serve as an advocate, organizer, and emotional anchor. At Sky Foundation, we know this firsthand—our leadership and committees are filled with survivors, caregivers, and families who have been through this process. You don’t have to navigate it alone.

Communicating With the Medical Team

Cancer care involves multiple specialists, appointments, and treatment phases. Clear communication helps your loved one receive the best care possible.

  • Prepare before appointments: Write down questions and bring all relevant documents.
  • Take notes: Record key points during visits or ask permission to record the conversation.
  • Clarify next steps: Confirm medications, procedures, and follow-up visits before leaving.
  • Advocate: Ensure your loved one’s preferences and concerns are heard.

Sky Foundation’s caregiver committees connect you with others who can share strategies for navigating these conversations with confidence.

Managing Appointments, Medications & Symptoms

Treatment schedules can feel overwhelming. Caregivers often manage the logistics that keep care on track.

  • Use calendars and apps: Track appointments, lab results, and medication schedules.
  • Create medication charts: Include dosage, timing, and side effects to watch for.
  • Track symptoms daily: Fatigue, nausea, or pain can change quickly—share updates with the medical team.
  • Plan for downtime: Bring snacks, water, or reading material for long treatment days.

Helping With Nutrition & Daily Needs

Treatment can affect appetite, taste, and digestion. Caregivers play a vital role in maintaining nutrition and daily comfort.

  • Encourage small, frequent meals: Large meals may feel overwhelming.
  • Focus on hydration: Offer water, smoothies, or broths.
  • Work with a dietitian: Ask for referrals to oncology dietitians.
  • Support mobility: Gentle walks or stretching can improve energy and reduce side effects.

Sky Foundation’s survivor and caregiver communities often share meal tips, hydration strategies, and ways to handle fatigue.

Encouraging Participation in Clinical Trials

Clinical trials may provide access to cutting-edge treatments, but caregivers often help navigate the details.

  • Search trial databases: Use TriCan Health to find open studies.
  • Ask doctors directly: Oncologists can explain eligibility and risks.
  • Plan logistics: Travel, lodging, and time commitments may be required.
  • Evaluate costs: Ask what is covered by the trial and what is out-of-pocket.

Sky Foundation connects families to knowledgeable voices who have gone through this process and can help you make informed choices.

Emotional Support During Treatment

Treatment days can be long, exhausting, and emotionally draining. Caregivers can support their loved one by:

  • Bringing comfort items like blankets, music, or favorite books.
  • Offering reassurance and staying present during treatments.
  • Recognizing when professional counseling may be beneficial.

Sky Foundation’s communities offer safe spaces to talk about these emotional highs and lows, connecting caregivers with others who truly understand.

Legacy of Care

Every step of caregiving during treatment leaves an impact. Sky Foundation’s Legacy Giving program allows families to continue that impact long after treatment by including Sky in a will or estate plan. Gifts can be designated to support caregiver resources, treatment education, or research projects, ensuring your caregiving journey helps others for years to come.

 

Key Takeaway

Supporting a loved one through treatment requires patience, organization, and compassion. From managing medications to advocating at appointments, caregivers play a vital role in helping loved ones navigate complex treatment plans. Sky Foundation offers survivor-led communities, caregiver resources, and Legacy Giving opportunities to ensure that your caregiving journey creates lasting impact—today and for the future.

read more

Coping With the Emotional Impact

Strategies for caregivers to manage stress, guilt, and emotional health.

Overview: Caregiving brings emotional highs and lows for both patient and caregiver.

  • Supporting your loved one’s mental health
  • Managing stress, anxiety, guilt, and burnout
  • Setting boundaries and seeking balance
  • When to consider counseling or therapy

Coping With the Emotional Impact

The emotional toll of pancreatic cancer is heavy, and it affects more than the patient. Caregivers, spouses, children, and close friends often feel fear, anxiety, sadness, or guilt while trying to stay strong for their loved one. These feelings are normal. At Sky Foundation, we know this firsthand—our board and caregiver committees are filled with people who have walked the same path. You are not alone, and with the right support, you can find strength and resilience in this journey.

Supporting Your Loved One’s Mental Health

A cancer diagnosis can bring shock, sadness, and uncertainty. Caregivers play a vital role in creating emotional safety.

  • Practice active listening: Give space for your loved one to express feelings without judgment.
  • Encourage open communication: Ask gentle questions like “How are you feeling today?” instead of “You’ll be fine.”
  • Normalize mental health care: Suggest counseling, support groups, or spiritual guidance as part of treatment.
  • Promote small joys: Reading, music, or outdoor walks can lift spirits during difficult days. 

Managing Caregiver Stress, Guilt & Burnout

Caregivers often put their own needs last, leading to burnout. Recognizing the warning signs early is key.

  • Look for warning signs: Irritability, constant fatigue, or withdrawing from friends.
  • Use respite care: Ask a family member to cover for you, or explore professional respite services.
  • Set realistic expectations: No one person can do everything. Focus on what matters most.
  • Release guilt: Self-care is not selfish. Rest and nourishment allow you to care more effectively.

Sky Foundation’s caregiver communities are safe spaces where you can share these feelings with others who truly understand.

 

Coping Strategies for Emotional Balance

In addition to counseling, you can build daily habits to protect your own emotional well-being:

  • Create routines: Structure reduces anxiety for both you and your loved one.
  • Practice mindfulness: Breathing exercises, journaling, or meditation can ground you.
  • Stay connected: Isolation increases stress. Schedule check-ins with friends or join a support group.
  • Maintain hobbies: Reading, exercise, or creative outlets help maintain your identity beyond caregiving. 

When to Seek Professional Counseling

Sometimes emotions become too heavy to manage alone. Consider counseling if you or your loved one:

  • Feel persistent sadness, hopelessness, or loss of interest in daily life.
  • Struggle to sleep, eat, or manage daily responsibilities.
  • Experience strained family or marital relationships.
  • Feel overwhelmed despite using coping strategies.

Professional help can provide tailored strategies for individuals, couples, or families navigating cancer together.

 

Building Strength Through Community

One of the strongest antidotes to isolation is connection. By joining Sky Foundation’s caregiver committees and survivor communities, you’ll meet others who have faced the same fears and challenges. These communities provide emotional support, practical strategies, and reassurance that you are not alone.

 

Legacy of Care

Caregiving leaves an impact far beyond the immediate journey. Sky Foundation’s Legacy Giving program offers a way to honor your caregiving role by supporting research, survivor-led programs, and caregiver resources through your will or estate. You can even choose the specific projects or initiatives you want to support, ensuring your love and care continue to shape the future of pancreatic cancer support.

 

Key Takeaway

The emotional impact of pancreatic cancer is as real as the physical one. Caregivers and families often feel guilt, fear, or exhaustion—but these emotions don’t have to be carried alone. By building coping strategies, seeking counseling when needed, and connecting with survivor-led communities at Sky Foundation, you can find resilience. Through Legacy Giving, you can also extend that resilience far into the future, ensuring your strength and care leave a lasting legacy.

read more

Practical & Financial Considerations

Tools for managing costs, insurance, clinical trial expenses, and planning.

Overview: Financial strain is common in cancer care—caregivers often manage logistics.

  • Navigating health insurance and medical bills
  • Understanding clinical trial costs and coverage
  • Applying for financial aid or patient assistance programs
  • Planning for in-home care, long-term care, or hospice

Practical & Financial Considerations

When a loved one is diagnosed with pancreatic cancer, caregivers often find themselves thrust into the role of financial organizer, insurance advocate, and care planner—all while trying to keep daily life afloat. These responsibilities can feel overwhelming, but with the right tools and knowledge, you can create structure and reduce stress. At Sky Foundation, we know this because our board and caregiver committees are filled with people who have faced these same challenges. You are not alone, and we are here to help.

Navigating Health Insurance & Medical Bills

Health insurance coverage can be confusing, especially when multiple specialists, hospital systems, and treatment plans are involved. Caregivers can take these steps to manage it effectively:

  1. Get Organized
    • Create a binder or digital folder for all Explanation of Benefits (EOBs), medical bills, and prior authorizations.
    • Keep a running list of reference numbers and the names of insurance representatives you speak with. 
  2. Ask Questions
    • Call the insurance company to confirm coverage before major procedures.
    • Ask hospitals if they have financial navigators who can explain charges line by line. 
  3. Explore Appeals
    • If insurance denies coverage, request an appeal immediately.
    • Document medical necessity with the help of your loved one’s doctor.

 

Understanding Clinical Trial Costs & Logistics

Clinical trials can be promising treatment options, but they often come with hidden costs. While most trials cover the experimental treatment itself, other expenses may fall on families.

  • Ask the right questions: Will insurance cover standard-of-care procedures during the trial? What about travel, lodging, or meals?
  • Look for financial aid: Some pharmaceutical companies and nonprofits offer travel or lodging stipends.
  • Explore local housing options: Hospitals may partner with Ronald McDonald House, Hope Lodge, or other organizations that provide low-cost housing. 

Planning for In-Home Care or Hospice

As treatment progresses, care needs often increase. Planning ahead helps reduce last-minute stress.

  1. Research Home Health Agencies
    • Interview agencies about licensing, background checks, and services offered.
    • Ask about respite care (short-term professional care to give you a break). 
  2. Know the Difference
    • Palliative care can begin at any stage to manage symptoms.
    • Hospice care is typically introduced when life expectancy is 6 months or less, focusing on comfort and quality of life. 
  3. Discuss Preferences Early
    • Have conversations about your loved one’s wishes for end-of-life care.
    • Document advance directives and designate a healthcare proxy if not already in place. 

Reducing Everyday Financial Strain

Medical bills aren’t the only financial pressure. Caregivers often face reduced income or increased household expenses. Consider:

  • Budget adjustments: Track monthly expenses and cut back where possible.
  • Assistance programs: Many hospitals offer sliding scale fees or patient assistance.
  • Tax benefits: Caregivers may qualify for deductions if providing more than half of a loved one’s support. 

Building Your Team of Support

No caregiver should carry the financial and logistical load alone.

  • Ask trusted friends or family to help with paperwork, bill tracking, or making calls.
  • Join Sky Foundation’s caregiver committees to learn strategies from others who’ve been in your shoes.
  • Reach out early—our network of survivors and caregivers can provide both practical advice and emotional reassurance. 

Key Takeaway

Managing the financial and logistical aspects of pancreatic cancer care can feel overwhelming, but with organization, planning, and community support, it is possible to reduce stress and stay focused on what matters most—caring for your loved one. Sky Foundation provides survivor-led insight, caregiver-focused communities, and Legacy Giving opportunities so families can navigate today’s needs while creating a meaningful impact for tomorrow.

read more

Resources for Spouses, Family & Friends

Guidance for partners, children, and friends offering support.

Overview: Different relationships bring unique caregiving challenges.

  • Spouses/partners: balancing intimacy, marriage, and caregiving
  • Parents and children: explaining cancer to kids and teens
  • Friends: how to help beyond “let me know if you need anything”

Resources for Spouses, Family & Friends

Pancreatic cancer affects more than just the person diagnosed—it impacts everyone close to them. Spouses, children, parents, and friends each play different roles in caregiving, and each relationship comes with unique challenges. At Sky Foundation, we understand this deeply: our board, volunteers, and committees are filled with survivors, spouses, parents, and friends who have lived through these experiences. This resource is here to provide practical guidance and emotional support for every member of the family circle.

Spouses & Partners

When a spouse or partner becomes a caregiver, the balance between “caregiver” and “partner” can feel complicated.

  • Communicate honestly: Talk openly about fears, needs, and boundaries. Silence often adds stress.
  • Preserve intimacy and normalcy: Shared meals, date nights at home, or short walks can help maintain your connection.
  • Plan together: Involve your partner in care decisions whenever possible, even if energy is low.
  • Seek couples counseling: Professional support can help manage the emotional weight.

 

Parents & Children

Parents often shoulder caregiving responsibilities, but children—especially teens—are also affected. Honest and age-appropriate conversations are essential.

  • Explain clearly: Use simple, direct language without hiding the truth.
  • Validate emotions: Reassure kids it’s okay to feel sad, angry, or confused.
  • Provide stability: Keep routines consistent when possible.
  • Invite participation: Teens may want to help—assign small, manageable roles like walking the dog or writing notes to the patient.

Sky Foundation’s family-focused communities include caregivers who can share strategies for talking with children and teens.

 

Friends & Extended Family

Friends often want to help but don’t know how. As a caregiver, you can guide them to provide meaningful support.

  • Offer specific suggestions: Instead of saying “let me know if you need anything,” suggest meals, childcare, or transportation.
  • Respect schedules: Understand treatment days may not allow for social visits.
  • Show consistency: Long-term help matters more than one-time gestures.
  • Stay connected: Regular texts or calls help caregivers feel less isolated.

Sky Foundation reminds friends that they are critical members of the support team. Reliable help lightens the load in tangible ways.

 

Coping Together as a Family Unit

Families often experience role shifts when a loved one is diagnosed. To cope together:

  • Hold regular family check-ins to share updates and feelings.
  • Assign roles (e.g., one person manages paperwork, another handles transportation).
  • Acknowledge each person’s contribution, big or small. 

Key Takeaway

Spouses, children, parents, and friends each bring vital support during a pancreatic cancer journey. By offering clear communication, practical help, and consistent presence, families and friends can reduce stress and strengthen hope. Sky Foundation offers survivor-led guidance, caregiver communities, and Legacy Giving opportunities to ensure your love and care leave a lasting impact.

read more

Building Your Support System

Connect with caregiver groups, families, and survivor communities.

Overview: No one should walk this journey alone.

  • Finding caregiver support groups (online and in-person)
  • Connecting with pancreatic cancer communities
  • Using technology to share updates with family/friends (e.g., CaringBridge)

Building Your Support System

Caregiving for someone with pancreatic cancer can feel isolating, but you don’t have to do it alone. Building a strong support system ensures that you have the emotional, practical, and spiritual resources needed to sustain your role. At Sky Foundation, we believe community is essential—our committees and survivor-led groups are here to connect you with people who truly understand this journey.

Why a Support System Matters

Research shows that caregivers with strong support systems experience lower stress, better health outcomes, and more resilience. A support system isn’t just about having people nearby—it’s about having the right people and resources around you.

  • Emotional support: Friends, family, or peers who listen without judgment.
  • Practical help: People who provide meals, rides, or help with errands.
  • Professional support: Counselors, medical teams, or financial advisors.
  • Community connection: Caregiver and survivor networks that offer shared experience and wisdom. 

Finding Caregiver Support Groups

Support groups—whether online or in-person—create safe spaces for caregivers to share their challenges and successes.

  • Local hospitals and cancer centers often host caregiver groups.
  • Online platforms such as Zoom or dedicated forums provide flexibility.
  • Specialized communities connect caregivers based on diagnosis, age, or family role.

Sky Foundation offers a Support Circle comprised of pancreatic cancer survivors and advocates who connect directly with you to help you along your path.  

 

Connecting With Other Families

Building relationships with other families facing pancreatic cancer can provide perspective and reassurance.

  • Share stories: Hearing from other caregivers helps normalize your own experiences.
  • Exchange tips: Learn strategies for managing appointments, nutrition, and stress.
  • Offer encouragement: Sometimes, the best support comes from someone who has “been there.”

 

Using Technology to Stay Connected

Technology can help caregivers share updates and reduce the number of repetitive conversations with extended family and friends.

  • CaringBridge & Lotsa Helping Hands: Platforms that allow you to update many people at once.
  • Shared calendars and apps: Keep family members informed about appointments and care needs.
  • Group chats: Quick way to coordinate meal trains, rides, or childcare.

 

Leaning on Professional & Faith-Based Support

Professional counselors, therapists, and clergy can help caregivers process grief, anxiety, or fear. Many hospitals offer oncology-specific social workers who understand the unique challenges of cancer caregiving.

  • Ask your hospital about in-house counseling or referrals.
  • Explore faith-based communities for spiritual encouragement.
  • Consider individual or family counseling when emotions become overwhelming. 

Key Takeaway

Building a strong support system is essential for caregivers of pancreatic cancer patients. From family and friends to survivor-led communities, technology, and professional guidance, these networks provide both strength and stability. Sky Foundation is here with survivor-led committees, community resources, and Legacy Giving opportunities that ensure your caregiving journey—and your resilience—create a lasting impact.

read more

End-of-Life Care & Grief Resources

Guidance on hospice, palliative care, and grieving with support.

Overview: Preparing for the later stages of the journey.

  • Understanding palliative vs. hospice care
  • Having difficult conversations with your loved one
  • Planning for legal and financial decisions
  • Coping with grief and finding support after loss

End-of-Life Care & Grief Resources

The later stages of pancreatic cancer often bring difficult decisions about care, comfort, and quality of life. For caregivers, family members, and friends, these moments are emotionally overwhelming. At Sky Foundation, we understand this deeply—our board, committees, and communities are filled with survivors and families who have faced these realities. This resource is here to help you navigate end-of-life care and grief with compassion and clarity.

Understanding Palliative vs. Hospice Care

Palliative care can begin at any stage of illness and focuses on symptom relief, emotional support, and quality of life alongside treatment.

Hospice care is typically recommended when life expectancy is six months or less. It emphasizes comfort, dignity, and support for both the patient and the family.

As a caregiver, ask your loved one’s medical team:

  • What symptoms can palliative care help with now?
  • When is hospice the right choice?
  • How can hospice support caregivers and families?

 

Preparing for Difficult Conversations

Facing the reality of end-of-life care requires open, compassionate communication.

  • Talk about wishes early: Ask about preferred settings for care (home, hospital, or hospice facility).
  • Document decisions: Use advance directives, living wills, or healthcare proxies.
  • Involve the whole family: Hold family meetings to share updates and avoid miscommunication.
  • Acknowledge emotions: Fear, sadness, or disagreement is natural—listening is as important as planning.

Supporting Caregivers & Families During End-of-Life

The emotional weight on caregivers during this stage is immense. Practical steps can help:

  • Accept help with meals, errands, or caregiving shifts.
  • Ask hospice teams about respite care options.
  • Take time for breaks, even short walks or naps.
  • Seek counseling or caregiver support groups to process grief in real time.

 

Grief Support After Loss

Grief is not linear—it unfolds differently for everyone. Some may feel deep sadness, while others feel numb or even relieved that their loved one is no longer suffering. All reactions are valid.

  • Give yourself permission to grieve: Avoid self-criticism for how you “should” feel.
  • Seek support groups: Talking with others who’ve experienced loss can reduce isolation.
  • Honor your loved one’s memory: Journaling, creating a photo book, or joining a memorial event can bring healing.
  • Support children and teens: Encourage open expression and age-appropriate explanations.

 

Key Takeaway

End-of-life care and grief are among the most difficult parts of the pancreatic cancer journey. By understanding the role of palliative and hospice care, having honest conversations, and seeking grief support, caregivers and families can honor their loved one’s wishes while protecting their own well-being. Sky Foundation provides survivor-led communities, caregiver support, and Legacy Giving opportunities to ensure your loved one’s story continues to inspire hope and change.

read more

Post-Recovery Care & Recurrence Prevention in Pancreatic Cancer

Healthy lifestyle tips and caregiver support after treatment.

Completing treatment for pancreatic cancer—whether surgery, chemotherapy, or participation in clinical trials—is a major milestone. For survivors, caregivers, and families, the next stage brings new questions: How do we support recovery? What can we do to reduce the risk of recurrence? At Sky Foundation, our survivor-led leadership and committees provide insight from people who have walked this road, offering practical guidance and hope for the future.

Supporting Physical Recovery

Recovery looks different depending on the type of treatment. Caregivers can help by focusing on daily needs that support healing:

  • Nutrition: Work with a dietitian to build a nutrient-rich plan that supports digestion and weight stability.
  • Hydration: Encourage consistent fluid intake to reduce fatigue and aid digestion.
  • Activity: Support gentle movement, like walking or light stretching, to rebuild stamina.
  • Rest: Allow for frequent breaks, naps, and quiet spaces to avoid overexertion.

📖 Resource: American Cancer Society – Life After Cancer
📖 Resource: Oncology Nutrition – Recovery Diet Guidance

Emotional Healing After Treatment

Transitioning from active treatment to survivorship can bring unexpected emotions. Survivors may feel relief, but also anxiety about recurrence.

  • Normalize emotions: Understand that fear and worry are common post-treatment.
  • Seek counseling: Professional help can address post-treatment stress.
  • Join survivorship groups: Connecting with others who’ve completed treatment provides perspective and reassurance.

Sky Foundation offers survivor and caregiver communities where families can share experiences and support one another in this new chapter.

📖 Resource: Cancer Support Community – Life After Cancer

Preventing Recurrence: Healthy Lifestyle Tips

While no plan can fully prevent recurrence, adopting healthy habits may reduce risk and improve overall well-being.

  • Nutrition: Focus on whole foods, fruits, vegetables, lean proteins, and healthy fats. Limit processed foods and red meat.
  • Exercise: Aim for at least 150 minutes of moderate exercise per week, adjusted for recovery stage.
  • Weight management: Maintain a healthy weight to reduce strain on the body.
  • Quit smoking & limit alcohol: Both increase risk of recurrence and other health issues.
  • Routine screenings: Follow up with all imaging, blood tests, and medical visits.

📖 Resource: National Cancer Institute – Cancer Prevention Overview
📖 Resource: Mayo Clinic – Pancreatic Cancer Follow-Up Care

Role of Caregivers in Survivorship

Caregivers remain important after treatment ends. Roles often include:

  • Helping manage lingering side effects such as fatigue or digestive issues.
  • Encouraging healthy lifestyle changes.
  • Accompanying loved ones to follow-up appointments.
  • Providing reassurance when fear of recurrence surfaces.

Sky Foundation’s caregiver committees provide opportunities to learn strategies directly from other families who have supported loved ones in recovery.

Legacy of Care

Celebrating recovery is also a time to reflect on impact. Many survivors and families choose to give back by supporting others still on this journey. Sky Foundation’s Legacy Giving program allows families to create lasting impact by funding survivorship programs, caregiver resources, or research through their will or estate planning—ensuring recovery stories inspire hope for years to come.

Helpful Resources at a Glance

Key Takeaway

Recovery after pancreatic cancer treatment is a new chapter filled with both hope and uncertainty. By focusing on physical healing, emotional support, and healthy lifestyle choices, caregivers and survivors can strengthen resilience and reduce recurrence risk. Sky Foundation provides survivor-led communities, caregiver resources, and Legacy Giving opportunities to ensure that recovery journeys inspire lasting hope and progress.

read more

Caregiver FAQ & Glossary for Pancreatic Cancer Support

Quick answers and definitions for caregivers and families.

Caregivers of pancreatic cancer patients face many questions—from daily responsibilities to complex medical terms. This resource provides quick answers to common questions and a glossary of important terms, so you can feel confident navigating the journey. At Sky Foundation, we know how overwhelming this can feel, and we’re here to make sure you don’t have to figure it out alone.

Frequently Asked Questions

Q: How do I know when to ask for help?
A: If you’re feeling physically exhausted, emotionally overwhelmed, or unable to manage daily responsibilities, it’s time to reach out. Ask friends or family to cover tasks, or explore respite care through hospice or home health services.

Q: What should I bring to medical appointments?
A: A notebook, medication list, insurance information, and prepared questions. Having a caregiver present helps patients remember details and feel supported.

Q: How do I talk to children about pancreatic cancer?
A: Be honest but age-appropriate. Use clear language, encourage questions, and reassure them that their feelings are normal.

Q: What if I feel guilty taking breaks?
A: Rest is necessary. Taking care of yourself allows you to provide better care for your loved one. Self-care is not selfish—it’s essential.

Q: Where can I find financial assistance?
A: Ask your hospital’s financial counselor, or explore national programs like the Patient Advocate Foundation and Cancer Financial Assistance Coalition.

Q: How do I connect with other caregivers?
A: Join Sky Foundation’s caregiver committees or online platforms like Cancer Support Community or CaringBridge.

Glossary of Key Terms

  • Advance Directive: A legal document outlining a patient’s healthcare wishes if they cannot speak for themselves.
  • Care Coordination: The organization of medical care across providers and facilities.
  • Clinical Trial: A research study that tests new treatments for safety and effectiveness.
  • Hospice Care: Comfort-focused care for patients with a life expectancy of six months or less.
  • Palliative Care: Care designed to relieve symptoms and improve quality of life, provided at any stage of illness.
  • Respite Care: Temporary relief for caregivers through short-term professional support.
  • Survivorship: The phase of care that begins after active treatment ends.

Building Confidence With Resources

Understanding caregiving terms and knowing where to turn for answers helps reduce stress and uncertainty. Sky Foundation’s survivor-led communities are filled with people who can explain these terms in plain language and share what they mean in real-life caregiving situations.

 

Legacy of Care

Every question you ask and every term you learn makes you a stronger advocate for your loved one. Sky Foundation’s Planned Giving options allows you to turn that advocacy into long-term impact by including Sky in your will or estate plan. 

 

Key Takeaway

Caregiving is filled with questions, and no one should feel lost or alone. By learning common terms, asking for help, and connecting with supportive communities, you can feel more confident and prepared. Sky Foundation is here with survivor-led insight, caregiver committees, and Legacy Giving opportunities to ensure your role as a caregiver creates a lasting impact.

read more

Recently Diagnosed with Pancreatic Cancer | Sky Foundation Guide

Being diagnosed with pancreatic cancer can feel overwhelming. This page is designed to provide accurate information, structured guidance, and trusted resources to help you understand your diagnosis and take your next steps with confidence.

Table of Contents

  1. Welcome & Understanding Your Diagnosis
  2. Next Steps After Diagnosis
  3. Treatment Options
  4. Clinical Trials Access
  5. Resources for Patients & Caregivers
  6. Glossary & FAQ 

Understanding Your Diagnosis

Pancreatic cancer begins in the pancreas, an organ that helps regulate blood sugar and produces enzymes for digestion. The most common type is pancreatic ductal adenocarcinoma (PDAC), which arises in the ducts of the pancreas. Less common types include neuroendocrine tumors.

Staging (localized, borderline resectable, locally advanced, or metastatic) is determined through imaging (CT, MRI, EUS) and biopsy.

📖 Resource: National Cancer Institute – Pancreatic Cancer

Next Steps After Diagnosis

Confirm Your Diagnosis and Stage Use imaging, biopsy, and bloodwork (including CA 19-9) to confirm the diagnosis and determine the stage of pancreatic cancer.

Seek a Second Opinion Outcomes often improve when care is coordinated through high-volume cancer centers. Sky Foundation partners closely with Henry Ford Health, Karmanos Cancer Institute, and the University of Michigan Rogel Cancer Center—and we can help connect you directly to any of these hospital systems upon request.

Get Genetic Testing Genetic testing is now standard for all pancreatic cancer patients. It not only helps guide treatment, but also gives your family valuable insight into their own potential risks. If you have a first-degree relative with pancreatic cancer, we strongly encourage scheduling genetic testing to protect yourself and your loved ones. Find a genetic councselor near you on our Genetic Counselors Page.

Understand Your Treatment PathwaysCommon treatment options include surgery, chemotherapy, radiation, clinical trials, and palliative care. Understanding each pathway helps you and your care team make informed decisions tailored to your needs.

Explore Clinical Trials Early – Access to new and emerging therapies can improve survival and quality of life. We recommend TriCan Health, which can match your specific case details to active clinical trials that may be the best fit for you.

Build a Multidisciplinary Care Team – Assemble a team that includes experienced surgeons, oncologists, gastroenterologists, and nutritionists. If you’re a candidate for the Whipple procedure, research your surgeon carefully—experience matters. Look for someone who has performed hundreds, ideally thousands of successful Whipple surgeries. Don’t hesitate to ask questions and gather all the information you need to make a confident decision.

Prepare for Appointments – Bring a trusted caregiver and a written list of questions to each visit. Staying organized ensures you get the answers and support you need at every step. Refer to our questions for yourself and your medical team page. 

Treatment Options

  • Surgery: Whipple procedure, distal pancreatectomy, or total pancreatectomy (curative intent).
  • Chemotherapy: FOLFIRINOX, gemcitabine + nab-paclitaxel, or gemcitabine alone.
  • Radiation Therapy: For borderline resectable or locally advanced disease, or symptom relief.
  • Targeted Therapy & Immunotherapy: PARP inhibitors for BRCA1/2 mutations; pembrolizumab for MSI-H tumors.
  • Clinical Trials
  • Palliative Care: Pain management, nutrition counseling, enzyme replacement, and emotional support.

Clinical Trials Access

Clinical trials test new therapies, including targeted drugs and immunotherapies. Patients often benefit from enrolling early. Clinical Trials are often looked at when patients “have no other options”.  But in the words of pancreatic cancer survivor, Kay Kays “Clinical Trials should be the Appetizer, not the dessert.” meaning these should not be a last resort, and rather a valuable resource at the beginning of your path.  

Click here to discover what works best for you on TriCan Health.

Resources for Patients & Caregivers

Support & Emotional Well-Being

Counseling & Mental Health
Emotional health is an important part of your care. Oncology social workers, psychologists, and cancer support groups can help manage anxiety, depression, and the emotional challenges that come with a diagnosis.

Peer Support Communities
At Sky Foundation, our community includes many individuals who have personally experienced a pancreatic cancer diagnosis. They offer understanding, encouragement, and valuable guidance.
Join our Facebook Support Group to connect with others, or consider getting more involved by joining one of our Boards or Committees to further support our mission.

Caregiver Health
Caring for a loved one with pancreatic cancer can be emotionally and physically demanding. Caregiver-focused programs and respite care can help prevent burnout. We recommend reaching out to Gilda’s Club for trusted caregiver support and resources.

Integrative Therapies
Incorporating practices such as meditation, yoga, gentle exercise, and nutrition support can improve overall well-being and quality of life during treatment.

Connect with a Sky Advocate
Many of our Board Members, Committee Members, and volunteers are either survivors or have supported a loved one through a pancreatic cancer path. We would be happy to connect you with someone who understands what you’re going through and can offer personal insight and encouragement.
Contact Annie, Sky’s Executive Director, to be matched with a supportive Sky Advocate:
📧 Annie@SkyFoundationInc.org
📞 248-385-5143

Glossary & FAQ

Adenocarcinoma: Most common pancreatic cancer type.
Biopsy: Tissue sampling to confirm diagnosis.
CA 19-9: Tumor marker used for monitoring, not diagnosis.
EUS (Endoscopic Ultrasound): Imaging test for detailed pancreas evaluation.
Whipple Procedure: Complex surgery for tumors in the head of the pancreas.
Palliative Care: Specialized care to improve quality of life alongside treatment.

FAQ Highlights:

  • How is staging determined? – Imaging, biopsy, and tumor spread.
  • Should I get genetic testing? – Yes, recommended for all patients.
  • What if surgery isn’t possible? – Options include chemotherapy, radiation, targeted therapy, or clinical trials.
  • Where can I find clinical trials? TriCanHealth.com

Closing Note

Pancreatic cancer care requires expert guidance, advanced treatments, and strong support systems. At Sky Foundation, we are here to connect patients and caregivers with top medical teams, clinical trial opportunities, and a supportive community that understands this journey.

read more

Understanding Your Diagnosis

Being told you have pancreatic cancer can feel overwhelming. You may have many questions, emotions, and uncertainties all at once. Please know—you are not alone. Sky Foundation was built to provide compassion, reliable information, and a community that understands what you’re going through.

Pancreatic cancer begins in the pancreas, a small but powerful organ located behind the stomach. The pancreas helps with digestion and regulates blood sugar. When abnormal cells grow and multiply there, they can form a tumor. The type and location of this tumor—and whether it has spread—determine your treatment options and next steps.

The Basics of Pancreatic Cancer

  • Types: The most common type is called pancreatic adenocarcinoma, which develops in the cells that line the ducts of the pancreas. Other, less common types include neuroendocrine tumors.
  • Stages: Like many cancers, pancreatic cancer is described in “stages” that reflect whether the cancer is confined to the pancreas, has spread nearby, or has traveled to other areas of the body.
  • Symptoms: Some people notice jaundice (yellowing of the skin or eyes), abdominal or back pain, unexplained weight loss, or digestive issues. Others are diagnosed after routine scans or lab tests.

Why Specialized Care Matters

Pancreatic cancer is complex, but outcomes improve when patients are treated at high-volume centers with experienced specialists. We are proud to have connections with Henry Ford Health and some of the best pancreatic cancer surgeons in the country. Through these partnerships, you have access to expert opinions, advanced imaging, genetic testing, and surgical options such as the Whipple procedure that are not always available at smaller hospitals.

Hope Through Research

Treatment is not one-size-fits-all. Alongside standard approaches like surgery, chemotherapy, and radiation, clinical trials are constantly testing new therapies that may provide better results. Sky Foundation helps connect patients to these opportunities so you can explore every possible option.

Moving Forward Together

Your diagnosis is just the beginning of your journey—but you don’t have to navigate it alone. Sky Foundation is here to:

  • Answer questions in plain language.
  • Connect you with world-class doctors, surgeons, and hospitals.
  • Provide information about clinical trials and research advances.
  • Offer emotional and community support from survivors and caregivers who understand.

NEXT ARTICLE: Next Steps After Diagnosis

read more

Next Steps After Pancreatic Cancer Diagnosis

A pancreatic cancer diagnosis raises urgent questions: What should I do first? Where do I go for care? What information do I need?
The following steps are widely recommended by leading cancer centers and medical guidelines.

1. Confirm the Diagnosis and Stage

Accurate diagnosis is essential before making treatment decisions. Tests may include:

  • Imaging scans – CT, MRI, or PET to identify tumor location and spread.
  • Endoscopic ultrasound (EUS) – allows close imaging and tissue biopsy.
  • Biopsy – confirms cancer type under a microscope.
  • Blood tests – including CA 19-9, a tumor marker sometimes elevated in pancreatic cancer.

These results help determine whether the cancer is localized, borderline respectable, locally advanced, or metastatic.

📖 Resource: American Cancer Society – Pancreatic Cancer Diagnosis

2. Seek a Second Opinion

Pancreatic cancer is complex and outcomes improve when treatment decisions are made by multidisciplinary teams at high-volume centers. Even if you feel confident in your current provider, a second opinion can confirm staging, expand your treatment options, and ensure surgical expertise is available.

Sky Foundation partners with Henry Ford Health and nationally recognized pancreatic surgeons to provide these expert evaluations. Please contact us for a connection to the team of doctors we suggest. 

3. Undergo Genetic and Biomarker Testing

Both germline (inherited) and somatic (tumor-specific) genetic testing are now standard of care for all pancreatic cancer patients. These tests can:

  • Identify inherited syndromes that may affect family members.
  • Reveal mutations (such as BRCA1/2, PALB2, MSI-H, KRAS, or NTRK) that guide targeted therapies or trial eligibility.
  • Inform risk for other cancers.

📖 Resource: National Cancer Institute – Pancreatic Cancer Genetics

4. Understand Treatment Pathways

Treatment depends on the stage and overall health of the patient. Standard approaches include:

  • Surgery – the only potentially curative option, performed if the tumor can be safely removed. The Whipple procedure (pancreaticoduodenectomy) is the most common.
  • Chemotherapy – drugs such as FOLFIRINOX or gemcitabine-based regimens, given before (neoadjuvant) or after (adjuvant) surgery, or as primary treatment for advanced disease.
  • Radiation therapy – may be used in selected cases to shrink tumors or relieve symptoms.
  • Palliative care – managing symptoms, nutrition, and quality of life from the start of treatment.

📖 Resource: NCCN Guidelines for Patients – Pancreatic Cancer

5. Explore Clinical Trials Early

Clinical trials test new drugs, combinations, and therapies. Enrolling early provides access to promising treatments that may improve outcomes beyond standard care.

Sky Foundation can help identify trials in Michigan and nationally.  Karmanos Cancer Institute (KCI) is a National Cancer Institute (NCI) Designated Comprehensive Cancer Center and has been since 1978. We are one of only 57 centers located in the United States. KCI is the only cancer hospital in the state of Michigan and our NCI designation ensures that we demonstrate scientific excellence as well as expertise in clinical, laboratory,  behavioral and population-based research. We offer our patients cancer treatment and clinical trials not available at other hospitals, as well as welcome patients coming in for consultation for a second opinion.

Karmanos Cancer Institute – https://www.karmanos.org/karmanos/clinical-trials-at-karmanos-cancer-institute

📖 Resource: ClinicalTrials.gov – Pancreatic Cancer Studies

6. Build Your Care Team

A strong care team typically includes:

  • Surgical oncologist – for surgical options.
  • Medical oncologist – for chemotherapy and systemic therapy.
  • Radiation oncologist – for targeted radiation when indicated.
  • Gastroenterologist – for digestive issues and stent placement.
  • Genetic counselor – for inherited cancer risk assessment.
  • Nutritionist and palliative care specialists – for symptom and diet management.

Multidisciplinary coordination improves survival and quality of life.

📖 Resource: Mayo Clinic – Pancreatic Cancer Treatment Team

7. Prepare for Appointments

Bring a trusted family member or caregiver to appointments and keep written questions. Helpful questions include:

  • What type and stage of pancreatic cancer do I have?
  • Is my cancer potentially operable?
  • What genetic or biomarker tests are recommended?
  • What are the treatment options in my situation?
  • Am I eligible for any clinical trials?
  • What side effects should I expect?

📖 Resource: American Cancer Society – Questions to Ask Your Doctor
📖 Resource:Sky Foundation Inc – Questions for Yourself & Medical Team

8. Consider Supportive Resources

Newly diagnosed patients and caregivers benefit from:

  • Patient navigation programs for clinical trial matching and insurance questions.
  • Survivor and caregiver support groups to reduce isolation.
  • Financial and legal counseling for managing treatment costs.

📖 Resource: CancerCare – Pancreatic Cancer Support

Here are some of the organizations we work closely with and collaborate on patient resources:

Key Takeaway

Your first steps should include confirming the diagnosis, seeking expert opinions, and undergoing genetic testing. Building a multidisciplinary care team and considering clinical trials early can expand treatment options and improve outcomes.

NEXT ARTICLE: Treatment Options

read more

Pancreatic Cancer Treatment Options | Surgery, Chemo & Care

Treatment for pancreatic cancer depends on the type, stage, and overall health of the patient. Care is typically provided by a multidisciplinary team that includes surgeons, oncologists, gastroenterologists, and palliative care specialists.

1. Surgery

Surgery is the only treatment with the potential to cure pancreatic cancer. However, only about 15–20% of patients are candidates because the cancer is often diagnosed at an advanced stage.

Common surgical procedures:

  • Whipple procedure (pancreaticoduodenectomy): Removes the head of the pancreas along with part of the stomach, duodenum, bile duct, and gallbladder. This is the most common surgery for tumors in the head of the pancreas.
  • Distal pancreatectomy: Removes the body and tail of the pancreas, often with the spleen.
  • Total pancreatectomy: Removes the entire pancreas, bile duct, gallbladder, and part of the stomach and small intestine. Patients will require lifelong insulin and enzyme replacement.

📖 Resource: Johns Hopkins Medicine – Surgery for Pancreatic Cancer

2. Chemotherapy (Systemic Therapy)

Chemotherapy uses drugs that circulate throughout the body to kill cancer cells. It can be given:

  • Neoadjuvant (before surgery): To shrink tumors and increase surgical success.
  • Adjuvant (after surgery): To reduce the risk of recurrence.
  • Primary treatment: For patients with locally advanced or metastatic disease.

Standard regimens include:

  • FOLFIRINOX (combination of fluorouracil, leucovorin, irinotecan, oxaliplatin) – typically for patients in good health who can tolerate intensive therapy.
  • Gemcitabine + nab-paclitaxel – often used when FOLFIRINOX is not appropriate.
  • Gemcitabine alone – an option for patients who cannot tolerate combination therapy.

📖 Resource: American Cancer Society – Chemotherapy for Pancreatic Cancer

3. Radiation Therapy

Radiation uses high-energy X-rays to kill cancer cells. It may be used in combination with chemotherapy (chemoradiation) or alone.

When radiation is used:

  • To shrink borderline resectable tumors before surgery.
  • To control locally advanced cancer when surgery is not possible.
  • To relieve symptoms such as pain or bleeding.

📖 Resource: National Cancer Institute – Pancreatic Cancer Treatment

4. Targeted Therapy and Immunotherapy

Advances in genetics and molecular profiling have led to new treatment options for selected patients.

  • PARP inhibitors (e.g., olaparib): For patients with inherited BRCA1/2 or PALB2 mutations.
  • MSI-H or dMMR tumors: May respond to immunotherapy drugs such as pembrolizumab (a PD-1 inhibitor).
  • TRK fusion-positive tumors: May respond to TRK inhibitors such as larotrectinib.

Testing tumors for genetic changes (biomarker testing) is critical to determine eligibility.

📖 Resource: FDA – Targeted Therapies for Pancreatic Cancer

5. Palliative and Supportive Care

Palliative care is not only for end-of-life care. It should begin at diagnosis to improve quality of life.

  • Pain management: Often involves medications, nerve blocks, or celiac plexus neurolysis.
  • Digestive support: Pancreatic enzyme replacement therapy (PERT) helps manage malabsorption.
  • Nutritional counseling: Maintains weight and strength during treatment.
  • Psychological and social support: Reduces anxiety and caregiver stress.

📖 Resource: Cancer.Net – Palliative Care for Pancreatic Cancer

Key Takeaway

Treatment may involve surgery, systemic therapy, radiation, or a combination of approaches. Genetic and biomarker testing are increasingly important for guiding therapy, and palliative care should be integrated from the start.

 

NEXT ARTICLE: Clinical Trials Access & Information

read more

Clinical Trials for Pancreatic Cancer | Access & Opportunities

Clinical trials are research studies that test new treatments, combinations, or approaches for pancreatic cancer. They play a critical role in advancing care and can provide patients with access to therapies not yet available outside the research setting.

Why Clinical Trials Matter

  • Expanded options: Trials may include targeted therapies, immunotherapies, or novel drug combinations.
  • Improved outcomes: Research shows that patients treated at centers offering clinical trials often live longer, even if they do not participate in a trial themselves.
  • Advancing science: Participation helps researchers understand pancreatic cancer better, improving treatment for future patients.

Types of Clinical Trials in Pancreatic Cancer

  • Phase I: Tests safety, dosage, and side effects of a new treatment.
  • Phase II: Evaluates how well a treatment works for a specific cancer type.
  • Phase III: Compares the new treatment against the current standard of care.
  • Precision medicine trials: Match treatment to genetic or molecular features of the tumor (e.g., BRCA mutations, MSI-H status).

How to Find a Clinical Trial

Patients and caregivers can search for trials using the U.S. National Library of Medicine’s official database:

Tricanhealth.com

This tool allows you to filter by:

  • Location (state or hospital system)
  • Stage of cancer
  • Type of intervention (drug, surgery, device)
  • Enrollment status

Karmanos Cancer Institute (KCI) is a National Cancer Institute (NCI) Designated Comprehensive Cancer Center and has been since 1978. We are one of only 57 centers located in the United States. KCI is the only cancer hospital in the state of Michigan and our NCI designation ensures that we demonstrate scientific excellence as well as expertise in clinical, laboratory,  behavioral and population-based research. We offer our patients cancer treatment and clinical trials not available at other hospitals, as well as welcome patients coming in for consultation for a second opinion.

KCI physicians and cancer researchers tirelessly engage with cancer research and the scientific advances made which assist us in determining treatment options and guide treatment courses. We are at the forefront of offering treatments that define the new standards of care. Our research programs, unique to KCI, are bringing safe, effective, and groundbreaking treatments from the laboratory bench to the patient’s bedside. From groundbreaking research to the most up-to-date therapies and individualized treatment plans, KCI is truly leading the fight against cancer. We are committed to being at the forefront of cancer treatment and offering tomorrow’s standard of care today! 

https://www.karmanos.org/karmanos/clinical-trials-at-karmanos-cancer-institute

When to Consider a Trial

  • At initial diagnosis, particularly for borderline resectable or advanced disease.
  • Before starting chemotherapy, to explore whether first-line trial options are available.
  • After progression on standard treatment, when new approaches may be available.

Support from Sky Foundation

Sky Foundation partners with leading institutions, including Henry Ford Health, to connect patients directly with appropriate trials. We also maintain relationships with national research networks, helping patients identify opportunities quickly and efficiently.

 

Key Takeaway

Clinical trials may offer access to new treatments that could improve outcomes. Patients are encouraged to ask their oncologist about trial eligibility as early as possible and use trusted tools like ClinicalTrials.gov to explore current opportunities.

 

NEXT ARTICLE: Resources for Patients & Caregivers

read more

Pancreatic Cancer Resources for Patients & Caregivers | Sky Foundation

Pancreatic cancer impacts not only the patient but also caregivers, family members, and loved ones. Accessing trusted resources can help with treatment planning, financial challenges, and emotional support.

Patient Navigation Services

Patient navigators are professionals who help guide patients through the healthcare system. They coordinate care, assist with scheduling, explain treatment options, and provide referrals for clinical trials. Many major cancer centers, including Henry Ford Health and the National Cancer Institute (NCI)-designated centers, offer navigation programs.

 

Financial and Legal Assistance

The cost of treatment can be a major concern. Several organizations provide financial and case management support:

Support for Caregivers

Caregivers play a vital role in managing appointments, medications, and emotional support. Dedicated caregiver programs can reduce burnout and improve patient outcomes.

Helpful tools include:

  • Caregiver workbooks for organizing medical information.
  • Respite care programs to provide temporary relief.
  • Counseling services for caregiver stress and grief support.

 

Educational Materials

High-quality educational guides help patients and caregivers make informed choices. Trusted options include:

  • Life After Whipple: The premier video series that documents everything you need to know about living post-Whipple surgery.
  • Lustgarten Foundation – Navigating Pancreatic Cancer Handbook: Comprehensive patient and caregiver guide.
  • National Comprehensive Cancer Network (NCCN) – Patient Guidelines: Evidence-based, plain-language explanations of diagnosis and treatment. 
  • American Cancer Society – Pancreatic Cancer Resources: Detailed information on symptoms, treatment, and coping strategies

Community & Peer Support

Engaging with peers and support groups helps reduce isolation and provides practical advice from those with lived experience. Options include:

Nutrition and Symptom Management

Since the pancreas is critical for digestion, patients often require dietary modifications. Resources can help with:

  • Pancreatic enzyme replacement therapy (PERT).
  • Medical nutrition counseling to maintain weight and strength.
  • Palliative care specialists for pain, fatigue, and symptom relief.
  • Life After Whipple Dietary Guidance – Digestion & Nutrition Episode

📖 Resource: Johns Hopkins Medicine – Nutrition and Pancreatic Cancer
📖 Resource: National Cancer Institute – Palliative Care
📖 Resource: Life After Whipple – Digestion & Nutrition

Key Takeaway

Patients and caregivers do not have to face pancreatic cancer alone. A wide range of resources—from financial assistance and patient navigation to peer support and nutrition guidance—are available to reduce stress and improve quality of life during treatment.

 

NEXT ARTICLE: Glossary & FAQ

read more

Pancreatic Cancer Glossary & FAQ | Patient & Caregiver Guide

Understanding medical terms and common questions can make the treatment journey less overwhelming. This section provides plain-language explanations of important terms and answers to frequent questions from patients and caregivers.

Glossary of Key Terms

Adenocarcinoma – The most common type of pancreatic cancer, beginning in the ducts that carry digestive enzymes.
📖 Resource: National Cancer Institute – Pancreatic Cancer

Biopsy – A procedure where a small tissue sample is removed and examined under a microscope to confirm the presence of cancer.

CA 19-9 – A blood test measuring a protein sometimes elevated in pancreatic cancer. It is not used alone for diagnosis but can help track treatment response.

Chemotherapy – Drugs that kill cancer cells throughout the body, often given in cycles.

Endoscopic Ultrasound (EUS) – A procedure using an endoscope with ultrasound to obtain detailed images and tissue samples of the pancreas.

Metastasis – The spread of cancer cells from the original tumor to other parts of the body, such as the liver or lungs.

Neoadjuvant Therapy – Treatment (usually chemotherapy or radiation) given before surgery to shrink a tumor.

Palliative Care – Specialized medical care focused on managing symptoms and improving quality of life, provided alongside cancer treatment.
📖 Resource: National Cancer Institute – Palliative Care

Resectable – A tumor that can be removed completely with surgery.

Whipple Procedure (Pancreaticoduodenectomy) – A complex surgery to remove the head of the pancreas, part of the stomach, the duodenum, bile duct, and gallbladder.

Frequently Asked Questions

Q: What type of pancreatic cancer do I have?
Most patients have pancreatic ductal adenocarcinoma (PDAC). Less common are neuroendocrine tumors, which behave differently and may have other treatment options.

Q: How is staging determined?
Staging is based on imaging scans (CT, MRI, PET), EUS, and biopsy. Doctors look at tumor size, lymph node involvement, and whether cancer has spread.
📖 Resource: American Cancer Society – Staging Pancreatic Cancer

Q: Is surgery possible in my case?
Surgery is only an option if the tumor has not spread and is not involving major blood vessels. A pancreatic surgeon at a high-volume cancer center is the best person to evaluate surgical eligibility.

Q: Should I get genetic testing?
Yes. Current guidelines recommend germline and tumor (somatic) testing for all patients. Results may guide treatment and inform family risk.
📖 Resource: National Cancer Institute – Pancreatic Cancer Genetics

Q: What if surgery is not possible?
Non-surgical treatment includes chemotherapy, targeted therapy, immunotherapy (in selected patients), and radiation. Clinical trials may also provide options.

Q: What questions should I ask my doctor?

  • What type and stage of pancreatic cancer do I have?
  • What are my treatment options?
  • Am I eligible for clinical trials?
  • What side effects should I expect?
  • How will treatment affect my daily life?

Q: Where can I find clinical trials?
Patients in the U.S. can search active studies here:
🔎 ClinicalTrials.gov – Pancreatic Cancer Trials

Key Takeaway

A strong understanding of terms and treatment basics helps patients and caregivers feel informed and prepared. Asking questions, keeping notes, and using trusted resources will empower you to play an active role in your care plan.

read more

Phase 1/2 Trial Launches for Innovative Pancreatic Cancer Immunotherapy

UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer.

A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced pancreatic cancer. The study, listed as NCT06625320, will evaluate the safety and effectiveness of KRAS-targeted TCR-T cell therapy in patients whose tumors carry KRAS mutations—one of the most common drivers of pancreatic cancer.

The trial is designed as a Phase 1/2 study, beginning with dose-escalation to assess safety before moving into an expansion phase that will explore potential anti-tumor activity. Eligible participants include patients with metastatic or unresectable pancreatic ductal adenocarcinoma who have already received standard treatments but seen their disease progress.

KRAS mutations are present in about 90% of pancreatic cancers, making them a leading target for new therapies. By engineering patients’ own T cells to recognize and attack KRAS-mutant tumor cells, researchers hope to create a more precise and lasting treatment option.

“This trial represents an exciting new direction for pancreatic cancer, where survival rates remain among the lowest of all cancers,” UCSF investigators stated. “Our goal is to see whether this highly personalized cell therapy can offer new hope for patients who currently have few options.”

The study is currently recruiting at UCSF, with outcomes focusing on safety, tolerability, and early signs of clinical benefit. If successful, this approach could lay the groundwork for future KRAS-targeted immunotherapies in pancreatic and other solid tumors.

Source: UCSF Clinical Trials, 2025

read more

FDA Approves NALIRIFOX as First-Line Treatment for Metastatic Pancreatic Cancer

FDA Approves NALIRIFOX for Metastatic Pancreatic Cancer

New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients

The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic pancreatic ductal adenocarcinoma (PDAC). The approval marks a major milestone in pancreatic cancer treatment, where options have long been limited and survival rates remain among the lowest of all cancers.

The approval was based on results from the NAPOLI 3 trial, which demonstrated that NALIRIFOX significantly improved overall survival (OS) and progression-free survival (PFS) compared with the standard gemcitabine plus nab-paclitaxel regimen. Patients receiving NALIRIFOX achieved a median OS of 11.1 months compared with 9.2 months in the control group. Median PFS was also longer, at 7.4 months vs. 5.6 months, respectively.

NALIRIFOX combines liposomal irinotecan (nal-IRI), 5-fluorouracil/leucovorin, and oxaliplatin into one regimen designed to deliver stronger anti-tumor activity. Importantly, the safety profile was considered manageable, with the most common side effects including neutropenia, diarrhea, and fatigue.

Experts believe this approval could change the standard of care for many patients. “This regimen provides a new option for patients newly diagnosed with advanced pancreatic cancer, where progress has historically been slow,” researchers noted.

The FDA decision also highlights the growing role of combination chemotherapy regimens tailored specifically to pancreatic cancer biology. With survival benefits observed across multiple subgroups, NALIRIFOX is expected to be widely adopted in oncology centers.

Looking ahead, researchers are exploring whether NALIRIFOX can be combined with emerging targeted therapies and immunotherapies to further extend patient outcomes. Additional studies are underway to evaluate its use in earlier-stage disease and in combination with novel agents.

This approval represents a rare but important step forward in the fight against pancreatic cancer, offering new hope to patients and families facing this aggressive disease.

Source: Cancer Network, 2025

read more

Immunotherapy for Pancreatic Ductal Adenocarcinoma: Barriers and Opportunities

pancreas cancer sky news

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes back. This article reviews why PDAC is so resistant to treatment and explores how immunotherapy could change outcomes.

The problem lies in PDAC’s tumor environment. These tumors block immune cells from attacking by surrounding themselves with dense scar-like tissue and sending out signals that shut down T cells. Even new drugs like checkpoint inhibitors, which have worked well in other cancers, have little effect in pancreatic cancer.

Researchers are testing new approaches to overcome these barriers, including:

  • Cancer vaccines that train the immune system to recognize tumor proteins.

  • Adoptive T-cell therapies, where immune cells are taken from the patient, strengthened in the lab, and then put back into the body.

  • Combination therapies, such as pairing immunotherapy with chemotherapy or radiation to make tumors easier to attack.

  • Targeting KRAS mutations, which drive most pancreatic cancers.

While results are still early, progress is happening. Scientists stress that combining treatments may be the key to success. By weakening the tumor’s defenses and boosting the immune system at the same time, there is hope that pancreatic cancer could eventually respond the way other cancers have to immunotherapy.

Citation: Halbrook CJ, Lyssiotis CA. Immunotherapy for Pancreatic Ductal Adenocarcinoma: Barriers and Opportunities. Front Immunol. 2022;13:793977.

read more

Pancreatic Cancer Vaccine Shows Early Promise in Preventing Recurrence

pancreatic cancer updates

UCLA’s Dr. Zev Wainberg discusses results from the AMPLIFY-201 trial and hopes for next-generation vaccines.

Researchers are exploring new ways to fight pancreatic cancer, one of the toughest cancers to treat. A recent phase 1 study, called AMPLIFY-201, tested a vaccine called ELI-002 2P in patients with KRAS-driven cancers. This “off-the-shelf” vaccine helps the immune system recognize and attack cancer cells after surgery and chemotherapy.

The study followed 25 patients, including 20 with pancreatic cancer. Results showed that patients who built strong T-cell immune responses had much lower chances of their cancer coming back. Almost two-thirds of patients developed this strong response, and most of them stayed cancer-free nearly 20 months after treatment—a major step forward in a cancer where relapse usually happens quickly.

Dr. Zev Wainberg of UCLA explained that these findings are important because pancreatic cancer often returns even after aggressive treatment. The vaccine may also encourage the immune system to attack more than just the KRAS mutation, a process called “antigen spreading,” which could boost overall protection.

The next step is a larger randomized phase 2 trial testing ELI-002 7P, a version of the vaccine that targets more KRAS mutations. That study has finished enrolling patients, and results are expected in 2026. If successful, it could move to a phase 3 trial and eventually FDA review.

Dr. Wainberg noted that the field of pancreatic cancer research is shifting toward immune-based and targeted therapies. He believes these new approaches bring real hope for improving survival.

📖 Citation: Feldman J, Wainberg ZA. Pancreatic Cancer Vaccine Aims for New Approach to Preventing Recurrence. Targeted Oncology. August 2025. Read the full article

read more

Pancreatic Cancer Vaccine Trial Moves Forward After Positive Safety Review

Sky pancreas cancer news

Independent committee recommends ELI-002 7P Phase 2 study continue without changes.

Elicio Therapeutics has announced encouraging news for its pancreatic cancer vaccine, ELI-002 7P. An independent committee (IDMC) reviewed early results from the AMPLIFY-7P Phase 2 study and recommended the trial continue as planned. This means the treatment has shown enough safety and early effectiveness to move forward without changes.

The vaccine is designed for people with pancreatic cancer driven by KRAS mutations, which are common in this disease. Unlike personalized treatments, ELI-002 7P is an “off-the-shelf” vaccine, making it easier and faster to produce. It works by training the immune system to recognize and attack cancer cells after surgery and chemotherapy.

The trial has enrolled 144 patients across 24 U.S. hospitals. Participants either receive the vaccine or standard care, which usually involves regular scans to watch for cancer returning. So far, ELI-002 7P has been well tolerated, and final results on disease-free survival are expected in late 2025.

“Patients with pancreatic cancer urgently need better options,” said Robert Connelly, CEO of Elicio. “We are encouraged by the committee’s recommendation and believe ELI-002 7P has the potential to make a difference.”

If results remain positive, the company plans to meet with the FDA to finalize a Phase 3 study. Elicio is also exploring the vaccine’s use in other cancers linked to KRAS mutations, including colorectal and lung cancer.

📖 Citation: Elicio Therapeutics, “Elicio Therapeutics Announces Positive Recommendation by IDMC to Continue ELI-002 7P Randomized Phase 2 Study in Pancreatic Cancer” (August 5, 2025). Read the full press release

read more

Off-the-Shelf Cancer Vaccine Shows Strong Results in Pancreatic and Colorectal Cancer Patients

pancreatic cancer news sky foundation

UCLA-led study reports durable immune responses and reduced relapse in patients with KRAS-driven cancers.

A groundbreaking study led by UCLA Health researchers has shown promising results for an experimental off-the-shelf cancer vaccine, ELI-002 2P, in patients with pancreatic and colorectal cancer. Published in Nature Medicine, the findings reveal that the vaccine elicited strong T-cell responses and extended both relapse-free and overall survival compared to historical outcomes.

The Phase 1 AMPLIFY-201 trial followed 25 patients with KRAS-driven pancreatic and colorectal cancers who had minimal residual disease following surgery. Results demonstrated that 84% of patients developed KRAS-specific immune responses, with some achieving complete clearance of cancer biomarkers. Patients with robust T-cell responses had dramatically longer relapse-free and overall survival, with many still disease-free at nearly 20 months of follow-up.

Unlike personalized vaccines, ELI-002 2P is designed as a standardized product, making it more accessible and faster to deploy. By using amphiphile technology to target lymph nodes directly, the vaccine effectively trains the immune system to attack cancer-driving mutations.

“This study shows that the ELI-002 2P vaccine can safely and effectively train the immune system to recognize and fight KRAS mutations,” said Dr. Zev Wainberg of UCLA. “For pancreatic cancer patients, where treatment options remain limited, this is an exciting step forward.”

A Phase 2 trial of an expanded version, ELI-002 7P, is now underway to target a broader range of KRAS mutations.

📖 Citation: UCLA Health News Release, “Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer” (August 12, 2025). Read the full article

read more

Seek Genetic Counseling If You Have a Family Member with Pancreatic Cancer

Genetic testing is essential for assessing inherited risks of diseases like Pancreatic Cancer. It is important to understand one’s ancestry to make informed medical decisions. It identifies potential health issues and enables you to proactively take measures or early intervention and allows for a more targeted healthcare approach.

Watch ouur recent webinar that highlights the importance of genetic counseling and the information surrounding the subject.

Michigan Genetic Testing Sites

Ann Arbor

U of M Cancer Genetics Clinic 

University of Michigan Cancer Center
Cancer and Geriatrics Center
1500 E. Medical Center Dr.
Ann Arbor, MI 48109-0638
734.763.2532

Elena Stoffel, MD, MPH

 

Cancer Genetics Program Cancer Center

Trinity Health (Previously known as Saint Joseph Mercy Hospital)
5303 Elliott Dr.

Ypsilanti, MI 48197

734.712.1541

Sommer Hayden, MS, CGC

Linsey Blakely, MS, CGC

Kelsie McVeety, MS, CGC

 


Dearborn

Genetic Risk Assessment For Cancer

Corewell Health East (formerly Beaumont Hospital Dearborn)

18181 Oakwood Blvd, Suite 102G
Dearborn, MI 48124
313.593.8483

Julie Zenger-Hain, PhD, FACMG
Lauren Jackson, MS, CGC
Katelyn Roberts, MS, CGC-PHP

Nicholas Serocki, MS, CGC

Angelina Sdao, MS, CGC

 


Detroit

Cancer Genetic Counseling Service

Karmanos Cancer Institute
4100 John R, Suite 312, Mailcode: HPO3GC
Detroit, MI 48201
313.576.8748

Michael S. Simon, MD, MPH

Nancie Petrucelli, MS, CGC

Kristian Wilks, MS CGC

Courtney Kokanakes, MS, CGC

Ashley Cosenza, MS, CGC

 

Henry Ford Health System Cancer Genetics Program

Henry Ford Health System Medical Genetics Department
3031 West Grand Blvd., Suite 700
Detroit, MI 48202
313.916.3188

Jacquelyn Roberson, MD

 


Farmington Hills

Cancer Genetic Counseling Service

Karmanos Cancer Institute
31995 Northwestern Highway
Farmington Hills, MI 48334
313.576.8748

 Kristian Wilks, MS, CGC


Grosse Pointe Woods

Cancer Genetics Program – Van Elslander Cancer Center

Ascension St. John Health System

19229 Mack Ave, Suite 18
Grosse Pointe Woods, MI 48236
313.647.3153

Allison Jay, MD, FACMG

 


Livonia

Cancer Genetic Counseling

Trinity Health Livonia (formerly St. Mary Mercy Livonia Hospital)

36475 Five Mile Road
Livonia, MI 48154
(734) 655-1185

Helen Burns, ANP, MSN, AGN-BC


Pontiac

Cancer Genetic Counseling

St. Joseph Mercy Oakland Hospital, Alice Gustafson Center

44405 Woodward Avenue, Suite 202
Pontiac, MI 48341
(248) 858-2270

Suzanne Jermstad, NP

Tyler Prince, MS, GC


Royal Oak

Corewell Health – Cancer Genetics Program

(Formerly Beaumont Health – Cancer Genetics Program)

3577 W. 13 Mile Rd., Suite 140
Royal Oak, MI 48073
248.551.3388

Dana Zakalik, MD

Alexis Gallant, GC

Aidan Kennedy, GC

Jordan Johnson, GC

Tonya Bortz, GC

 


Southfield

Ascension Providence Cancer Institute

22301 Foster Winter Drive, Third Floor
Southfield, MI 48075
248.849.3281

Samira Ahsan, MD 

 


Troy

Corewell Health – Cancer Genetics Program

(Formerly Beaumont Health – Cancer Genetics Program)

44344 Dequindre Rd., Suite 350
Sterling Heights, MI 48314
248.551.3388

Dana Zakalik, MD
Richard Zekman, DO
Kristina Ivan, MS, CGC

 


West Bloomfield

Henry Ford Health System Cancer Genetics Program

Henry Ford West Bloomfield Hospital
6777 West Maple Rd.
West Bloomfield, MI 48322
313.916.3188

Jacquelyn Roberson, MD


Additional resources on the importance of genetic counseling, testing, support, and locations nationwide, please contact My Faulty Gene.

 

read more

Where To Begin

Where to Begin

Receiving a diagnosis or learning about pancreatic cancer can feel overwhelming. Sky Foundation is here to help guide you toward reliable, trusted resources and local experts so you can take the next steps with confidence.

Start with Trusted Information

The National Cancer Institute (NCI) and American Cancer Society (ACS) offer accurate, research-based information about pancreatic cancer. Both are excellent places to begin learning about the disease, treatment options, and available resources.

Visit cancer.gov or cancer.org for detailed guidance on:

  • Understanding pancreatic cancer and its types

  • Available treatments, drugs, and clinical trials

  • Causes, prevention, and screening options

  • Coping resources for patients and families

There are two main types of pancreatic cancer:

  • Adenocarcinoma – accounts for about 95% of cases

  • Neuroendocrine tumors – make up roughly 5% of cases

The National Institutes of Health (NIH) also supports extensive research into the causes, diagnosis, and prevention of cancer through partnerships with leading public and private institutions around the world.

Learn About Symptoms and Risk Factors

Early detection saves lives. Educate yourself and your loved ones on the symptoms and risk factors associated with pancreatic cancer. Visit our Learn The Symptoms & Risk Factorspage for detailed information on what to look for and when to consult your physician.

Finding a Doctor

Because Sky Foundation is based in Southeast Michigan, we are proud to recommend three leading regional cancer centers that specialize in pancreatic cancer care:

  • Henry Ford Health

  • Barbara Ann Karmanos Cancer Institute

  • University of Michigan Rogel Cancer Center

If you’re looking for providers outside our area, visit the American Society of Clinical Oncology’s website at cancer.net. This site helps patients:

  • Find qualified oncologists and specialists near you

  • Learn about treatment options and side effect management

  • Access lists of questions to ask your doctor, including:

    • After receiving a diagnosis

    • When choosing treatment or surgery

    • During chemotherapy or radiation

    • When planning follow-up care

Identifying an Advocate

You don’t have to face this alone. We encourage every patient to choose a trusted advocate—a family member, friend, or caregiver—who can accompany you to appointments, take notes, ask questions, and help process information. Having another listener present ensures that important details aren’t missed during a stressful time.

How Sky Foundation Can Help

Sky Foundation offers information, advocacy, and connections to help you navigate the healthcare system, find trusted doctors, and access emotional and community support. Our mission is to raise awareness and fund research for the early detection, prevention, and treatment of pancreatic cancer—bringing hope and strength to patients and families every step of the way.

If you need additional guidance or wish to be connected to a Sky Advocate, contact Sky’s Executive Director, Annie Dalton Flores, at:
📧 Annie@SkyFoundationInc.org
📞 248-385-5143

read more

Monica Barbour, Esq

Monica is the senior attorney at the University of Detroit Mercy and corporate secretary to its Board of Trustees. She previously served as corporate counsel in the Detroit offices for what is now JP Morgan Chase.

read more

Mary Beth Castorri

Mary Beth and her husband Ron owned a film and video production company  producing award winning commercials all over the country for many years.

In 2013, her husband, Ronald Castorri, then 66, was diagnosed with pancreatic cancer.  The one person they turned to for help and advice was Sheila Sky Kasselman.  She was there for them at every turn and for all the tests and scans.  He fought this disease for 15 months but it eventually took his life.  Mary Beth joined Sky Foundation in 2014 and has been an avid supporter ever since with Sheila as her biggest cheerleader.  Her goal is to carry on her wishes to raise research funds and awareness of this terrible disease.
read more

William H. Powers, Jr. ChFC®, RICP®

William (Bill) is a registered representative and investment advisor representative of LPL Financial, member FINRA/SIPC a financial planning firm based in suburban Detroit.   He holds the Charter Financial Consultant (ChFC®) and Retirement Income Certified Professional (RICP®) designations.

Securities and advisory services offered through LPL Financial LLC, member FINRA/SIPC.

read more

University Of Michigan Lab Work

Passion for Change Runs In The Family

The passion to find a cure for pancreatic cancer runs in the family! Sheila’s granddaughter, Samantha Kasselman works in the Frankel Lab at the University of Michigan Rogel Cancer Center studying the role of inflammation in pancreas cancer induction. She recently presented at the Department of Surgery Moses Gunn Research Conference, and did a fantastic job! It is so important to keep this passion running through generations so that we can continue to find breakthrough research and fight this disease.

Dr. Timothy Frankel and his team in his cancer research lab, Thursday, January 25, 2018.

University of Michigan | Howard Crawford Laboratories

Immunotherapy

The Pasca di Magliano, Lyssiotis, Frankel and Crawford laboratories at the University of Michigan have teamed up to devise ways to make immunotherapy effective in fighting pancreatic cancer. Dr. Pasca di Magliano has discovered that macrophages, a specialized inflammatory cell, are the cells primarily responsible for establishing the immune suppressed environment by both sending signals to immune cells to ignore the tumor and then signaling to the tumor cells to have them express high levels of PD-L1.

In turn, the tumor cells instruct the macrophages to also make PD-L1. In an attempt to disrupt this cycle, Dr. Crawford has identified one of the primary molecules the macrophages use to turn on tumor cell PD-L1, known as HBEGF. Meanwhile, Dr. Lyssiotis has found that tumor cell metabolites are responsible for telling the macrophages to make PD-L1. With this knowledge in hand, Dr. Frankel, a surgeon who specializes in immunotherapy research, is involved in translating these observations to the clinic, combining immune checkpoint inhibitors with therapies to disrupt the cellular crosstalk responsible for establishing the immunosuppressive environment in preclinical models of human pancreatic cancer.

Immunotherapy Team Members

Marina Pasca di Magliano, PhD

Costas Lyssiotis, Phs

Timothy Frankel, MD

read more

Pancreatic Cancer Leads to a New Direction

“In September of 2007, I was found to have a very small tumor at the head of the pancreas, which changed my life in an instant.”

“For the ten months before my diagnosis I was a mess. I suffered from depression, I lost weight, I was nauseous and exhausted. I also became diabetic (only temporarily at that point) and had sludge in my gallbladder. But it wasn’t until my bile duct collapsed and I became jaundiced that a diagnosis was made. My tumor was too small to be seen in a CT scan so pancreatic cancer was initially ruled out. My doctors noted that I had what they thought was a pancreatic cyst; this turned out to be a tumor. ” READ FULL ARTICLE ON LET’S WIN

*original content from letswinpc.org*

read more

Raising Awareness & Funding Innovative Research for the Early Detection & Treatment of Pancreatic Cancer

Our Mission

Pancreatic cancer is the third leading cause of cancer-related deaths in the United States. Sky Foundation awards seed-money grants to scientists and clinicians from coast to coast who are pursuing research of great promise in the areas of early detection, prevention or treatment.

This start-up funding helps researchers get to the point in their work where they can successfully attract financial support from the National Institutes of Health and other national funding sources.

Sky Foundation hosts several events throughout the year to raise public awareness and to be a listening ear to those recently diagnosed. The gatherings, which are both educational and entertaining, are designed to get participants thinking about their pancreas, an organ seldom talked about or understood. Genetic counseling also is introduced as a proactive measure for those with the disease in their family. The events also bring participants in contact with medical researchers who share their latest findings and insights.

Executive Director

Annie Dalton Flores serves as Executive Director of Sky Foundation, bringing over eight years of passionate leadership to the fight against pancreatic cancer. Having grown within the organization from assistant to director, Annie is deeply committed to expanding awareness, advancing research, and addressing health disparities in early detection. Her vision is bold: to make Sky Foundation Michigan’s leading force in pancreatic cancer advocacy and impact.

Click here to read the press release from DBusiness on her leadership announcement.

Business Manager

Jamie Guyor serves as Business Manager of Sky Foundation, bringing more than 13 years of philanthropic experience and a strong background in project management. Fueled by a passion for purpose-driven work, Jamie plays a key role in keeping Sky’s programs running efficiently, supporting the team and board while building operational strength needed to further Sky’s mission.  Jamie is committed to helping Sky Foundation grow its reach and deepen its impact in the fight against pancreatic cancer.

About Our Founder

Sky Foundation was established by Sheila Sky Kasselman in 2008 while she was recovering from surgery for cancer of the pancreas. One of her doctors suggested she create a foundation dedicated to raising awareness and funding medical research for the early detection and treatment of the disease.

“Our goal is to find an early detection method to increase survival rates and save lives.”

Sheila was diagnosed with the most common form of pancreatic cancer in the fall of 2007. She completed chemotherapy, radiation and had “Whipple” surgery to remove her tumor.

She used her energy and positive attitude to provide hope and knowledge when people face the challenges of a disease that they never anticipated. “When I was diagnosed, I didn’t know one person who had the disease,” she said. “Throughout the whole ordeal of treatment, I thought, ‘I wish I had someone to talk to other than my doctors.’ But there was no one for me to reach out to.”

“I decided, when I founded Sky, that I needed to become the person who people could reach out to – and that is who I have become. I want to give those diagnosed with the disease and those who have lost loved ones great hope. Through awareness and research we are helping to save lives.”

“Our attendees and financial contributors represent an ever-growing community of people who have lost a loved one to the disease,” Sheila adds. “Like me, they believe they are funding hope through research.”

Sheila was diagnosed with a recurrence of pancreatic cancer in her lung in May 2020.  After almost 3 years of battling this second diagnosis, Sheila passed away peacefully from complications of pancreatic cancer on Saturday, February 25, 2023.  Sky Foundation will continue its very important mission of raising awareness and funding pancreatic cancer research for years to come, as her legacy.

Governance

The foundation is led by a Governing Board and a Scientific Advisory Committee.

The Governing Board is an all-volunteer board and has fiduciary responsibility for the philanthropic entity. Board members assist with fundraising and also with events to raise awareness.

Sky’s President

Shannon Crone

As President of the Sky Foundation Board, Shannon Crone brings both leadership and heart to our mission of advancing pancreatic cancer awareness and research. A long-time advocate for early detection, Shannon has been instrumental in guiding Sky Foundation’s strategic growth, expanding partnerships, and strengthening our community impact.

Her passion for helping others stems from personal connections to the cause and a deep commitment to supporting patients and families affected by pancreatic cancer. Under Shannon’s leadership, Sky continues to shine brighter—building hope, funding research, and empowering change across Michigan and beyond.

MEET THE GOVERNING BOARD

The Scientific Advisory Committee reviews grant applications and makes recommendations on funding to Sky’s Governing Board. All Scientific Advisory Committee members are researchers or doctors best in their field.

MEET THE SCIENTIFIC ADVISORY COMMITTEE

Financials

The Sky Foundation is a 501(c)3 organization located in Bloomfield Hills, Mich. Its 990 tax returns are available through GuideStar, the nonprofit entity that collects, organizes and presents tax and other information for all IRS-registered nonprofit organizations.

Download our 2023 Financial Statements > > 

Download our 2022 Financial Statements > > 

Download our 2021 Financial Statements > > 

Download our 2020 Financial Statements > > 

read more

How You Can Help & Get Involved

Financial Support for Medical Research

At Sky Foundation, Inc., every dollar donated fuels hope. Your support directly funds innovative pancreatic cancer research, advancing early detection, prevention, and treatment for patients and families nationwide.

Research Funding

Donations to Sky Foundation are awarded as grants to scientists and clinicians whose work shows the greatest promise in improving pancreatic cancer outcomes.

All proposals are carefully reviewed by our Scientific Advisory Committee (SAC) — a team of top medical experts who evaluate each project for innovation, impact, and feasibility.

  • Seed grants begin at $50,000, providing the early funding needed for researchers to grow their ideas into competitive projects.
  • Sky-funded researchers often go on to secure major national grants from the National Institutes of Health (NIH) and other institutions.
  • Annual progress reports ensure transparency and track the measurable impact of each funded project.

🎥 Hear from our researchers about how Sky seed grants are driving breakthroughs at our annual event:

👉 Stars in Our Sky

 

 

Planned Giving

You can create a lasting legacy by supporting Sky Foundation through planned giving. These gifts extend your impact well into the future, fueling the next generation of discoveries.

Ways to Give:

  • Legacy gifts through your will or trust

  • Gifts of appreciated stock or mutual funds

  • Donor-advised fund grants

📘 Learn more about planned giving options and how your generosity can sustain pancreatic cancer research:

👉 Planned Giving Information

For personal guidance, contact Annie Dalton Flores at 📧 Annie@SkyFoundationInc.org | ☎ 248-385-5143

 Attend an Event

Sky Foundation hosts inspiring events year-round — each one designed to raise awareness, fund research, and connect our community.

Signature Events Include:

  • Sky Movement – community-driven awareness campaign
  • Pickleball Tournament – fun, fitness, and fundraising
  • Doc-Tail Mixer – networking with Michigan’s medical community
  • Night Sky Gala – our largest annual event each November

Proceeds from every event fund seed grants that drive research in early detection, prevention, and treatment.

👉 View Upcoming Events

Committee Involvement

Your time and expertise can make a difference.
Join a committee or volunteer at Sky Foundation events to help raise awareness and strengthen our impact.

Ways to Get Involved:

  • Join the Fundraising Committee to plan annual events.
  • Volunteer at the Ann Arbor Art Fair or other community events.
  • Support Sky’s mission alongside passionate advocates and survivors.

Interested? Contact Annie Dalton, Executive Director, at
📧 ADalton@SkyFoundationInc.org | ☎ 248-385-5143

Sponsor Special Events

Partner with Sky Foundation as an event sponsor and help bring hope to thousands affected by pancreatic cancer. Sponsorship levels are available for all events, offering meaningful recognition for your business while supporting lifesaving research.

To learn more about sponsorship opportunities, contact:
📧 ADalton@SkyFoundationInc.org | ☎ 248-385-5143

Spread the Word

Awareness saves lives.
Sharing information about pancreatic cancer symptoms and risk factors helps others detect the disease earlier and seek timely care.

Ways to Get Involved:

  • Participate in the Sky Movement
  • Join a committee or volunteer team
  • Take a shift at the Ann Arbor Art Fair
  • Share our posts on social media to reach more families

Together, we can create a future where pancreatic cancer is detected early and treated successfully.

 

read more

Pancreatic Cancer Risk Factors

An estimated 64,050 Americans will be diagnosed with pancreatic cancer in 2023, more people than ever before. Approximately 50,550 Americans are expected to die from the disease this year.

And while pancreatic cancer is currently the 10th most commonly diagnosed cancer in the U.S., it remains the third-leading cause of cancer-related deaths. Pancreatic cancer is on track to become the second leading cause of cancer-related deaths before 2030.

Illustration of the pancreas

Image courtesy WebMD

Risk factors

  • Cigarette smoking – doubles the risk of pancreatic cancer
  • Age – 80 percent of pancreatic cancer patients develop the disease between ages 60 and 80
  • Race – the disease is more common about African Americans than it is among Caucasians
  • Gender – the disease is more common in men that women
  • Religious background – due to a genetic mutation, the disease is more common among Ashkenazi Jews
  • Chronic pancreatitis – long-term inflammation has been linked to the disease
  • Diabetes mellitus – can be a symptom of pancreatic cancer; long-term adult-onset diabetes also may increase the risk of developing the disease
  • Obesity – excess weight significantly increases the risk of pancreatic cancer
  • Diet – those high in meats, cholesterol, fried foods and cured meats may increase the risk of pancreatic cancer
  • Genetics – the breast cancer syndrome (BRCA2 and PALB2), familial atypical multiple mole melanoma syndrome (FAMMM), Lynch syndrome (also known as hereditary non-polyposis colorectal cancer syndrome), and the Peutz-Jeghers syndrome all increase risk

The Sol Goldman Pancreatic Cancer Research Center at The Johns Hopkins University offers detailed information on the above risk factors, including hereditary/genetic factors.

In addition, the National Familial Pancreas Tumor Registry (NFPTR) at the Goldman Center may be helpful.

read more

What We Do

 At Sky Foundation, Inc., we raise awareness and fund innovative research for the early detection and treatment of pancreatic cancer.
Through community events, social media, and unique awareness initiatives, we educate the public, connect families with resources, and raise critical funds for research.

We also emphasize the importance of genetic counseling for individuals with a family history of pancreatic cancer—empowering people to take preventive action and detect the disease early.

Research

Our mission begins with research. Each year, Sky Foundation awards seed grants to doctors and scientists pursuing promising pancreatic cancer studies and medical treatment breakthroughs.

  • Each seed grant provides $50,000 in initial funding to help researchers advance early-stage projects.

  • Our Scientific Advisory Committee (SAC), composed of leading experts in pancreatic cancer, carefully reviews and recommends which proposals to fund.

  • Researchers provide annual progress updates to ensure accountability and to evaluate potential for continued or expanded funding.

Sky Foundation’s grants help fill critical funding gaps—enabling innovative ideas to grow into competitive projects that can later secure major support from the National Institutes of Health (NIH) and other national institutions.

We proudly fund researchers across Michigan and throughout the United States, expanding our impact coast to coast.

👉 Meet Our Researchers

Awareness

Awareness and education are at the heart of everything we do.
Because pancreatic cancer is often detected late, recognizing even subtle body changes and understanding your family history can make all the difference.

Our awareness efforts include:

  • Public events that bring communities together for education and action

  • Campaigns during Pancreatic Cancer Awareness Month (November) and throughout the year

  • Partnerships with hospitals, corporations, and community organizations to share life-saving information

By spreading awareness, we aim to give people the knowledge and confidence to advocate for themselves and their loved ones.

Genetic Counseling

Genetic counseling is an important step toward prevention and early detection.
We recommend genetic counseling for anyone with:

  • A first-degree relative (parent, sibling, or child) diagnosed with pancreatic cancer

  • Two or more second-degree relatives (grandparents, aunts, uncles, or cousins) with a history of the disease

🔗 Find a Genetic Counselor in Michigan

Sky Support Circle

At Sky Foundation, we know that community is one of the most powerful forms of healing.
Our Sky Support Circle is made up of dedicated Sky Advocates—individuals who have walked a similar path, either as survivors or as advocates for loved ones affected by pancreatic cancer.

These volunteers provide:

  • Emotional support and understanding during difficult times

  • Guidance drawn from their own lived experience

  • Connection to resources, hope, and community

Whether you’re newly diagnosed, caring for a loved one, or seeking understanding after loss, our Sky Advocates are here to listen and share insight that only someone who’s been there can provide.

If you’d like to be connected with a Sky Advocate, reach out to:
📧 Annie Dalton, Executive Director – Annie@SkyFoundationInc.org
📞 248-385-5143

Outreach

Our outreach efforts extend beyond research and awareness—we believe in building community and sparking conversations that matter.

  • We host special events that unite patients, caregivers, and supporters.

  • We collaborate with media partners, civic groups, and local organizations to share resources and encourage early detection.

  • We produce educational videos, often using relatable humor to open dialogue about a difficult subject.

Visit our YouTube Channel to watch Sky Foundation videos that educate, inspire, and bring hope to those impacted by pancreatic cancer.

read more

David R. Calver, MD

David Calver

David is a physician with more than three decades of experience in group practice. He holds an appointment as clinical assistant professor at Wayne State School of Medicine in Detroit.

read more

Henry P. Lee, Esq

Henry Lee

Henry is an attorney with the law firm Howard and Howard where he focuses on business law, estate planning and tax law. He is chairman of the estate planning section of the business and corporate group at the firm.

read more

Ramzi M. Mohammad, PhD

Mohammad

Wayne State University, Detroit

Mohammad is the director of the Gastroenterology Cancer Research Center and Scientific Member of the Developmental Therapeutics Program at Wayne State University. Mohammad has more than 30 years of cancer research experience and publications exceeding 150 in peer-reviewed journals, reviewed papers and book chapters.

He has established a number pancreatic cancer cell lines and was among the first to develop orthotropic models in animals. He has studying the effects of new anticancer agents and marine products as well as standard chemotherapeutic drugs.

read more

Making Breakthroughs

Dr. Aatur Singhi | University of Pittsburgh

DNA-based testing of pancreatic cyst fluid (PCF) is a useful adjunct to the evaluation of pancreatic cysts (PCs). A prospective study was performed to evaluate preoperative PCF DNA testing.  Over 43-months, 626 PCF specimens from 595 patients were obtained by endoscopic ultrasound (EUS)- fine needle aspirations and assessed by targeted next-generation sequencing (NGS). A separate cohort of 159 PCF specimens was also evaluated for KRAS/GNAS mutations by Sanger sequencing.

Sky Foundation grant has helped fund the second version of PancreaSeq or PancreaSeqV2. PancreaSeqV2 makes significant improvements to the evaluation of human clinical pancreatic cyst samples to inclusion of additional genomic alterations involved in pancreatic cysts, pancreatic cancer and neuroendocrine neoplasms of the pancreas. Further, PancreaSeqV2 improves the sensitivity of detecting genomic alterations in pancreatic cyst fluid. Currently, PancreaSeqV2 is being validated on a retrospective cohort of 99 pancreatic cysts with our goal of implementing it clinically by early August.

 

Pancreatic Cancer Action Network: Early Detection Initiative

Pancreatic Cancer Action Network logo. (PRNewsFoto/Pancreatic Cancer Action Network)

The chance of survival when detecting pancreatic cancer early enough is 40% for up-to five years; but when discovered late there is less than a 5% survival rate.

The foundation of Early Detection Initiative (EDI) is timely completion of the New Onset of Diabetes (NOD) cohort and support related research to translate results into clinical practice.

25% of patients diagnosed with pancreatic cancer have experienced NOD. It is important to conduct a study with an enriched high risk population so that the study can be more focused. There have been studies conducted to reveal that 40-50% of pancreatic cancer patients have diabetes and 50-80% of these patients were diagnosed with NOD.

Goal

·    Create research dataset

·    Screen patients

·    Show stage shift

Design

·    10k patients, followed for 3 years

·    Recruit from Electronic Health Records (EHR) in integrated healthcare systems

·    Serial biospecimens to validate promising emerging biomarkers

·    Imaging CT or MRI

Research Update:

Research Committee is advancing preparations for the official launce of the EDI Initiative.

University of Michigan | Howard Crawford Laboratories

Immunotherapy

The Pasca di Magliano, Lyssiotis, Frankel and Crawford laboratories at the University of Michigan have teamed up to devise ways to make immunotherapy effective in fighting pancreatic cancer. Dr. Pasca di Magliano has discovered that macrophages, a specialized inflammatory cell, are the cells primarily responsible for establishing the immune suppressed environment by both sending signals to immune cells to ignore the tumor and then signaling to the tumor cells to have them express high levels of PD-L1.

In turn, the tumor cells instruct the macrophages to also make PD-L1. In an attempt to disrupt this cycle, Dr. Crawford has identified one of the primary molecules the macrophages use to turn on tumor cell PD-L1, known as HBEGF. Meanwhile, Dr. Lyssiotis has found that tumor cell metabolites are responsible for telling the macrophages to make PD-L1. With this knowledge in hand, Dr. Frankel, a surgeon who specializes in immunotherapy research, is involved in translating these observations to the clinic, combining immune checkpoint inhibitors with therapies to disrupt the cellular crosstalk responsible for establishing the immunosuppressive environment in preclinical models of human pancreatic cancer.

Immunotherapy Team Members

Marina Pasca di Magliano, PhD

Costas Lyssiotis, Phs

Timothy Frankel, MD

read more

Aatur Singhi, MD, PhD | University of Pittsburgh Medical Center

University Of Pittsburgh Medical Center

Dr. Singhi is a surgical pathologist with sub-specialty training in gastrointestinal, liver, and pancreatobiliary pathology. His diagnostic expertise includes both neoplastic and non-neoplastic diseases of the gastrointestinal system, liver, biliary tract, pancreas and peritoneum.

His current research focus is primarily translational in the area of gastrointestinal, pancreatic, hepatobiliary and peritoneal pathology

 

CLICK HERE TO READ ABOUT DR. SINGHI’S RESEARCH FUNDED BY SKY FOUNDATION, INC.

 

read more

Pancreatic Cancer Action Network

Founded in 1999, the Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support.  We are determined to improve outcomes for today’s patients and those diagnosed in the future.

 

Read The December 2020 Research Update Here. 

CLICK HERE TO READ ABOUT PANCAN’S RESEARCH FUNDED BY SKY FOUNDATION, INC.

 

12-year Survivor Funds Research and Gives Hope

read more

Christine B. Jeryan | Secretary

Christine is an accomplished weaver and pro bono textile historian at Henry Ford Museum in Dearborn, Mich., where she also coordinates the activities in Greenfield Village’s weaving shop. She has spent her career in museum services, scientific research, writing and editing.

read more

Pamela Itkin-Ansari, PhD | Sanford-Burnham-Prebys Medical Discovery Institute, University of California, San Diego

Sanford-Burnham-Prebys Medical Discovery Institute, University Of California, San Diego

My lab recently found that a single gene reprograms pancreatic cancer cells back to their original cell type, halting tumor growth in animals. There is precedent for a cell reprogramming strategy in cancer treatment; this approach changed a once lethal leukemia, acute promyelocytic leukemia (APL), into a curable disease. To exploit the previously unrecognized plasticity of pancreatic cancer cells, we developed a drug screening platform. From a screen of 4300 known drugs we have identified several compounds that appear to regulate the pathway of interest.  With help from the Sky Foundation we propose to evaluate the potential ‘hits’ in mechanistic studies in cells and in an animal model of pancreatic cancer. Our ultimate goal is to identify a drug, or drug combination, that can be translated to the clinic as a novel reprogramming therapy for pancreatic cancer.

read more

Howard Crawford, PhD

Howard C. Crawford, PhD

Scientific Director, Henry Ford Pancreatic Cancer Center | Chief Scientific Officer, Sky Foundation Scientific Advisory Committee

Overview

Dr. Howard Crawford is the Scientific Director of the Henry Ford Pancreatic Cancer Center in Detroit, Michigan, and serves as Chief Scientific Officer (CSO) of the Sky Foundation Scientific Advisory Committee (SAC). His research focuses on how tumor cells and immune cells communicate to drive pancreatic cancer progression and on developing early-detection biomarkers for at-risk patients.

Leadership & Roles

  • Scientific Director – Henry Ford Pancreatic Cancer Center (Henry Ford Health)
  • Professor – Molecular & Integrative Physiology and Internal Medicine, University of Michigan
  • Director – Pancreas Research Program, University of Michigan, Ann Arbor
  • Chief Scientific Officer – Sky Foundation Scientific Advisory Committee (SAC)

Role within Sky Foundation

As CSO of Sky Foundation’s Scientific Advisory Committee, Dr. Crawford works closely with Sky’s leadership, staff, and partners to shape research priorities that advance the Foundation’s mission in early detection, education, and advocacy. He oversees the scientific review process, ensuring fairness, rigor, and alignment with Sky’s goals. After grant submissions close, Dr. Crawford coordinates with external reviewers so that each proposal receives multiple independent evaluations, with no reviewer from an applicant’s own institution. He leads the SAC’s in-depth deliberations to narrow six leading proposals down to three finalists, which are then presented to Sky’s Governing Board for final approval.

Sky Foundation-Funded Research

Project Title: Immune Responses in Patients with Chronic Pancreatitis and Pancreatic Cancer
Principal Investigator: Howard Crawford, PhD
Institution: University of Michigan / Henry Ford Health System

Project Summary

Supported by Sky Foundation, Dr. Crawford’s lab investigates the immune responses in patients with chronic pancreatitis and pancreatic cancer to identify early detection biomarkers that can distinguish between these conditions using a simple blood test.

  • Focuses on how risk factors, such as chronic pancreatitis, promote tumor initiation and progression.
  • Utilizes two advanced technologies to map immune-tumor interactions:
    • Technique 1 – CyTOF: Measures up to 30 cell-surface markers simultaneously, creating a detailed immune-cell signature from circulating blood.
    • Technique 2 – Single-Cell Sequencing: Analyzes gene expression of individual immune and tumor cells to reveal cellular communication networks.

Key Findings

  • Unique Immune Signature: Pancreatic cancer patients display a distinct immune-cell profile compared to normal and chronic pancreatitis patients.
  • Early Detection Potential: Longitudinal blood-sample testing of at-risk patients aims to detect emerging immune signatures that signal tumor formation before symptoms occur.
  • Novel Crosstalk Pathways: Single-cell data reveal new immune-suppressive communication channels between tumor and immune cells—potential therapeutic targets for immune reactivation.

Scientific Contributions

  • Leader in pancreatic tumor biology and immune microenvironment research.
  • Published extensively on cell signaling, inflammation, and early tumor initiation mechanisms in PDAC.
  • Advocates for multidisciplinary, translational approaches linking basic research and clinical discovery.

Selected Publications

  • Inflammation and the origins of pancreatic cancerTrends in Cancer, 2022 (PubMed)
  • Immune cell crosstalk defines early pancreatic tumorigenesisGastroenterology, 2021 (PubMed)
  • Pancreatitis as a predisposing condition for pancreatic cancerAnnual Review of Pathology, 2020 (PubMed)

Recognition & Impact

  • Nationally recognized expert in pancreatic inflammation, immune-oncology, and tumor initiation.
  • Recipient of Sky Foundation Research Grant supporting discovery of early immune biomarkers.
  • Frequent keynote speaker and advisor for national pancreatic research initiatives.

Institutional Links

 

read more
1 2
Page 1 of 2